Disorders of mineral metabolism

E4_MINERAL_MET

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — E83 Cause of death: ICD-10 — E83 2 out of 7 registries used, show all original rules.	3506
4. Check minimum number of events None	3506
5. Include endpoints E4_COPPER_MET E4_IRON_MET E4_ZINC_MET E4_PHOS_MET E4_MG_MET E4_CA_MET E4_MINERAL_METNAS	3581
6. Filter based on genotype QC (FinnGen only)	3451

Control definitions (FinnGen only)

Control exclude: E4_METABOLIA

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: E70-E90
Name in latin: Perturbationes metabolismi mineralium

NAME	E4_MINERAL_MET
CONTROL_EXCLUDE	E4_METABOLIA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	E4_COPPER_MET\|E4_IRON_MET\|E4_ZINC_MET\|E4_PHOS_MET\|E4_MG_MET\|E4_CA_MET\|E4_MINERAL_METNAS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E83
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	E83
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Disorders of mineral metabolism based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	20513	11800	8560
Only index persons	17898	10452	7446
Unadjusted period prevalence (%)
Whole population	0.30	0.34	0.24
Only index persons	0.34	0.38	0.28
Median age at first event (years)
Whole population	64.04	65.92	61.47
Only index persons	63.59	65.28	61.23

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3451	1954	1497
Unadjusted period prevalence (%)	0.69	0.69	0.69
Median age at first event (years)	62.75	61.67	64.16

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3581: Matched controls
35810

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

24.8

319.9

228

N17.9

ICD-10 Finland

Acute renal failure, unspecified

9.8

308.4

376

425

E83.50

ICD-10 Finland

Hypercalcemia

506.4

307.7

1568

E83.1

ICD-10 Finland

Disorders of iron metabolism

387.5

307.7

584

BAA60

NOMESCO Finland

Total thyroidectomy

15.0

307.7

298

215

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

41.2

307.7

260

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

28.3

307.7

399

158

BBA30

NOMESCO Finland

Excision of lesion of parathyroid gland

29.0

307.7

279

104

106

Kela drug reimbursment

Hypoparathyroidism

144.1

307.7

191

A12AA04

ATC

calcium carbonate; oral

25.0

307.7

284

123

E87.6

ICD-10 Finland

Hypokalaemia

30.2

307.7

325

118

A11CC03

ATC

alfacalcidol; systemic

32.6

307.7

577

210

E21.3

ICD-10 Finland

Hyperparathyroidism, unspecified

26.3

307.7

241

E83.51

ICD-10 Finland

Hypocalcemia

1549.9

307.7

834

E21.0

ICD-10 Finland

Primary hyperparathyroidism

22.6

307.7

385

190

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

7.3

305.6

489

764

E86

ICD-10 Finland

Volume depletion

66.5

290.0

159

E83.4

ICD-10 Finland

Disorders of magnesium metabolism

1484.6

284.0

273

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

3.2

252.5

1748

8205

TPH00

NOMESCO Finland

Phlebotomy

47.2

247.5

145

BBA40

NOMESCO Finland

Subtotal parathyroidectomy

46.6

236.6

139

A11CC02

ATC

dihydrotachysterol; oral

109.9

228.1

117

E89.2

ICD-10 Finland

Postprocedural hypoparathyroidism

2194.9

226.3

217

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

11.9

224.9

234

210

E83.58

ICD-10 Finland

Idiopathic hypercalciuria

730.3

211.9

207

C03CA01

ATC

furosemide; systemic

3.0

205.2

1394

6311

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

4.9

199.1

486

1116

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

10.8

185.9

205

200

321

Kela drug reimbursment

Paricalcitol and cinacalcet

26.0

184.0

128

H05BX01

ATC

cinacalcet; oral

24.2

183.4

131

E87.5

ICD-10 Finland

Hyperkalaemia

33.7

173.8

111

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.7

170.6

627

1941

JN4AD

NOMESCO Finland

Body CT examination

3.6

159.4

615

1961

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.5

156.1

1944

11495

N02AA05

ATC

oxycodone; systemic

2.9

154.9

904

3684

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

5.8

154.8

300

559

N19

ICD-10 Finland

Unspecified kidney failure

6.8

154.1

252

397

E21.2

ICD-10 Finland

Other hyperparathyroidism

34.4

152.8

N18.8

ICD-10 Finland

Other chronic renal failure

8.5

151.4

201

250

E83.39

ICD-10 Finland

Other disorder of phosphorus metabolism

1538.5

150.0

145

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

13.5

149.0

141

108

SPAT1074

SPAT

Venesection

26.3

144.6

100

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.0

144.6

786

3068

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

4.5

142.2

370

887

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.1

138.7

686

2533

M04AA01

ATC

allopurinol; systemic

3.1

137.2

660

2397

TK800

NOMESCO Finland

Hemodialysis

8.6

136.7

178

216

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.9

133.5

794

3242

M05BX04

ATC

denosumab; parenteral

4.0

129.8

402

1096

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.4

127.8

1271

6640

104

Kela drug reimbursment

Thyroid insufficiency

3.9

126.2

409

1151

BB1BQ

NOMESCO Finland

Extensive scintigraphy of parathyroid gland, 2 isotopes, SPECT and low-dose CT

27.2

124.4

EP1AE

NOMESCO Finland

Neck ultrasound examination

4.1

124.3

364

952

Z49.1

ICD-10 Finland

Extracorporeal dialysis

11.3

123.6

131

120

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

11.8

122.7

126

110

D64.9

ICD-10 Finland

Anaemia, unspecified

3.2

118.4

533

1851

H03AA01

ATC

levothyroxine sodium; systemic

2.5

117.0

1032

5074

WW500

NOMESCO Finland

Blood transfusion

4.8

114.8

271

598

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

4.0

114.7

349

937

B03XA02

ATC

darbepoetin alfa; parenteral

7.3

112.5

168

239

V03AE01

ATC

polystyrene sulfonate; oral

12.3

111.8

112

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

14.7

110.2

AA1AD

NOMESCO Finland

CT of head and brain

2.3

109.1

1120

5859

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.2

109.0

476

1620

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

13.4

108.6

103

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

2.8

107.7

623

2483

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

11.5

107.4

112

100

127

Kela drug reimbursment

Transplant complication

9.4

106.4

128

140

JN3AD

NOMESCO Finland

Abdominal CT examination

2.9

104.9

552

2089

TPX10

NOMESCO Finland

Implantation of vascular injection port

5.5

103.0

204

386

BBA20

NOMESCO Finland

Exploration of parathyroid gland

33.1

101.3

E21.1

ICD-10 Finland

Secondary hyperparathyroidism, not elsewhere classified

52.6

99.4

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.3

97.4

951

4834

TPH04

NOMESCO Finland

Cathetrisation of vein

2.3

96.0

888

4407

Z51.5

ICD-10 Finland

Palliative care

3.2

94.9

419

1430

R53

ICD-10 Finland

Malaise and fatigue

2.3

93.3

940

4830

D35.1

ICD-10 Finland

Benign neoplasm: Parathyroid gland

26.7

91.6

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.7

91.3

574

2374

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

18.8

90.9

KA1AE

NOMESCO Finland

Kidney ultrasound examination

5.6

90.3

175

324

Z94.0

ICD-10 Finland

Kidney transplant status

10.7

89.5

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

8.4

88.3

116

142

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

13.7

87.9

L04AA06

ATC

mycophenolic acid; systemic

7.2

87.4

131

187

TPH00, ,

SPAT

44.0

87.2

XW000

NOMESCO Finland

Bone marrow biopsy

4.2

86.6

245

621

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

17.8

86.2

N18.0

ICD-10 Finland

End-stage renal disease

10.6

85.3

A02BC02

ATC

pantoprazole; systemic

2.1

85.3

2531

19169

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

18.9

84.9

SPAT1262

SPAT

Handing over of treatment supplies

2.4

84.2

725

3466

L04AD02

ATC

tacrolimus; systemic

11.0

83.7

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

4.6

82.2

201

455

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

5.2

82.1

175

353

WZC00

NOMESCO Finland

Treatment plan or consultation

2.0

81.9

1414

8832

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.1

81.5

971

5295

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

5.5

81.3

161

304

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.8

80.9

441

1688

137

Kela drug reimbursment

Uraemia requiring dialysis

11.6

80.3

ZX120

NOMESCO Finland

Intravenous

2.8

80.2

437

1673

H02AB06

ATC

prednisolone; systemic

1.9

79.7

1802

12299

Z49.0

ICD-10 Finland

Preparatory care for dialysis

10.7

79.7

E83.59

ICD-10 Finland

Other disorders of calcium metabolism

795.8

79.7

R50.9

ICD-10 Finland

Fever, unspecified

2.4

78.9

638

2959

N17.8

ICD-10 Finland

Other acute renal failure

9.6

78.8

J01MA12

ATC

levofloxacin; systemic

2.2

76.6

771

3921

WZC30

NOMESCO Finland

Teaching

2.3

74.6

683

3336

TPH07

NOMESCO Finland

Cathetrisation of artery

2.7

74.5

465

1905

A41.9

ICD-10 Finland

Sepsis, unspecified

4.3

74.2

196

471

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.1

72.2

855

4623

196

Kela drug reimbursment

Paricalcitol and cinacalcet

15.8

71.8

R11

ICD-10 Finland

Nausea and vomiting

2.9

71.5

365

1345

A03FA01

ATC

metoclopramide; systemic, rectal

2.1

71.1

898

4970

H02AB09

ATC

hydrocortisone; systemic

5.5

70.9

141

267

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

7.3

70.8

105

148

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

7.1

69.1

105

152

B99

ICPC

Blood/lymph/spleen disease other

14.3

68.2

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

8.9

67.8

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

3.6

67.6

236

692

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

8.2

67.5

112

B05DB

ATC

Hypertonic solutions

13.0

67.5

A10AB05

ATC

insulin aspart; parenteral

3.0

67.1

314

1102

C90.0

ICD-10 Finland

Multiple myeloma

7.4

67.0

136

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.6

66.9

434

1808

WF049

NOMESCO Finland

Radiotherapy of metastasis

3.8

66.8

213

587

V03AE02

ATC

sevelamer; oral

14.5

66.5

205

Kela drug reimbursment

Chronic hypertension

2.0

65.4

984

5772

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

15.2

64.8

C08CA01

ATC

amlodipine; oral

1.8

64.7

1390

9148

A10AE04

ATC

insulin glargine; parenteral

2.7

63.8

365

1426

C07AB07

ATC

bisoprolol; oral

1.8

62.8

1714

12096

N02AX02

ATC

tramadol; systemic, rectal

1.8

62.7

1573

10826

3025

Kela drug reimbursment

Calcium carbonate

17.0

62.6

B05DA

ATC

Isotonic solutions

11.2

62.4

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

11.6

62.1

V03AE03

ATC

lanthanum carbonate; oral

18.7

60.5

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

3.6

60.3

205

590

WX408

NOMESCO Finland

General anesthesy, balanced

1.9

59.9

979

5876

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.0

59.9

860

4942

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

7.5

59.4

115

I50.9

ICD-10 Finland

Heart failure, unspecified

2.3

59.3

495

2308

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

3.4

59.2

219

666

Z49.2

ICD-10 Finland

Other dialysis

10.7

58.6

ZXD05

NOMESCO Finland

Urgent procedure

1.9

58.2

1071

6669

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

4.8

58.0

134

289

E20.9

ICD-10 Finland

Hypoparathyroidism, unspecified

93.1

58.0

H03BB01

ATC

carbimazole; oral

3.8

57.9

186

515

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.6

57.6

376

1566

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

3.7

57.3

191

542

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.1

57.3

647

3403

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.5

57.3

207

620

103

Kela drug reimbursment

Diabetes, insulin-treated

1.9

57.1

927

5538

TK810

NOMESCO Finland

Hemofiltration

13.8

57.1

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

3.2

56.4

236

774

153

Kela drug reimbursment

Lenalidomid

10.0

56.1

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

9.7

55.7

M10.9

ICD-10 Finland

Gout, unspecified

2.9

55.6

285

1049

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

12.7

55.5

B01AB10

ATC

tinzaparin; parenteral

2.4

55.5

424

1899

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

14.5

55.4

D44.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Thyroid gland

6.3

54.9

151

L04AX04

ATC

lenalidomide; oral

9.7

54.0

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

3.8

53.9

171

469

R06.0

ICD-10 Finland

Dyspnoea

1.9

53.8

950

5813

E21

ICD-10 Finland

Hyperparathyroidism and other disorders of parathyroid gland

23.2

53.7

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

8.6

53.7

I10

ICD-10 Finland

Essential (primary) hypertension

1.7

53.4

2087

16019

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.9

52.4

265

968

JN4BD

NOMESCO Finland

Extensive body CT

2.3

52.4

444

2078

E83.9

ICD-10 Finland

Disorder of mineral metabolism, unspecified

+∞

52.2

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

51.7

834

4949

E20.8

ICD-10 Finland

Other hypoparathyroidism

515.3

51.6

E55.9

ICD-10 Finland

Vitamin D deficiency, unspecified

10.7

51.5

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

16.7

51.3

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

12.0

50.6

N16.3*E83.50

ICD-10 Finland

Nefrocalcinosis NEC

259.0

50.2

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

50.0

1474

10420

A04AA01

ATC

ondansetron; systemic, rectal

2.5

49.5

349

1504

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.1

49.5

517

2629

E05.0

ICD-10 Finland

Thyrotoxicosis with diffuse goitre

4.3

49.1

128

304

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.2

48.6

457

2229

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

4.3

48.2

126

300

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

5.1

48.0

101

201

UJF32

NOMESCO Finland

Coloscopy

1.8

48.0

960

6068

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

3.9

47.8

144

381

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

5.0

47.6

104

214

J01MA02

ATC

ciprofloxacin; systemic

1.7

47.6

1364

9535

H02AB02

ATC

dexamethasone; systemic

2.1

47.2

479

2406

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

8.5

47.2

WW200

NOMESCO Finland

Immunization

4.0

46.8

135

346

WX402

NOMESCO Finland

General anaesthesia

1.9

46.6

757

4485

KH1AD

NOMESCO Finland

CT of urinary organs

3.5

46.4

168

503

A12AA06

ATC

calcium lactate gluconate; oral

67.1

46.2

N02BE01

ATC

paracetamol; systemic, rectal

2.1

46.0

3146

27748

M14.5*E83.1

ICD-10 Finland

Arthropathy in haemochromatosis

+∞

45.9

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

4.0

45.8

132

338

A10AC01

ATC

insulin (human); parenteral

2.6

45.7

274

1092

L28

ICPC

Limited function/disability (L)

1.9

45.6

642

3627

SPAT1254

SPAT

Administration of medicine

2.0

45.4

542

2891

B03XA01

ATC

erythropoietin; parenteral

8.0

45.2

V03AG01

ATC

sodium cellulose phosphate; systemic

74.0

45.1

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.1

45.0

201

684

A10BH05

ATC

linagliptin; oral

3.1

45.0

197

663

329

Kela drug reimbursment

Lenalidomide

10.3

44.9

A06AD11

ATC

lactulose; oral

2.0

44.9

538

2873

130

Kela drug reimbursment

Malignant tumour

2.3

44.7

374

1736

N18.4

ICD-10 Finland

Chronic kidney disease, stage 4

10.8

44.4

B01AB05

ATC

enoxaparin; parenteral

1.7

44.1

1123

7568

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.0

44.0

545

2942

XX3DW

NOMESCO Finland

Time consuming IT work

2.1

43.9

450

2265

N03AX16

ATC

[U] pregabalin

1.8

43.9

825

5100

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.1

43.9

190

635

N20.0

ICD-10 Finland

Calculus of kidney

4.3

43.8

116

279

C03DA01

ATC

spironolactone; oral

2.2

43.5

421

2072

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.9

43.0

130

345

BAA40

NOMESCO Finland

Unilateral lobectomy of thyroid gland

4.0

42.9

125

323

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

42.9

1212

8385

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.2

42.7

389

1869

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.9

42.6

612

3474

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.9

42.5

202

712

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.4

42.2

298

1283

GD1AD

NOMESCO Finland

Thorax CT examination

2.6

42.1

251

997

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.4

41.8

316

1402

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

13.0

41.7

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.0

41.7

188

643

D86.0

ICD-10 Finland

Sarcoidosis of lung

5.8

41.6

133

E61.2

ICD-10 Finland

Magnesium deficiency

111.4

40.8

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

5.1

40.5

169

ZX108

NOMESCO Finland

Inhalation

7.8

40.4

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.4

40.1

300

1325

C02AC05

ATC

moxonidine; oral

3.0

39.8

183

633

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.6

39.7

235

929

ZX114

NOMESCO Finland

Intramuscular

5.6

39.7

139

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.7

39.3

221

852

R4190

NOMESCO Finland

Nutritional therapy

3.2

39.1

161

522

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.9

39.0

593

3420

T90

ICPC

Diabetes non-insulin dependent

1.8

38.9

786

4941

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

11.5

38.7

SPAT1263

SPAT

Sampling

1.6

38.6

1423

10445

E83.0

ICD-10 Finland

Disorders of copper metabolism

+∞

38.6

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

4.7

38.5

196

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

3.9

38.5

116

307

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

3.7

38.4

122

335

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

5.2

37.7

153

C03AA03

ATC

hydrochlorothiazide; oral

2.2

37.6

337

1605

N05BA04

ATC

oxazepam; oral

1.7

37.4

886

5811

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

3.7

37.2

120

333

UKC02

NOMESCO Finland

Cystoscopy

1.9

37.0

566

3266

M05BA04

ATC

alendronic acid; oral

2.1

36.5

358

1767

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.9

36.4

481

2644

WX892

NOMESCO Finland

Monitored bed care

2.4

36.3

268

1176

Z3231

NOMESCO Finland

Registered nurse

1.7

36.3

923

6162

J01DB01

ATC

cefalexin; oral

1.7

36.2

2853

24889

C08CA13

ATC

lercanidipine; oral

1.9

35.9

507

2850

2754A

ICD-9 Finland

Disorders of mineral metabolism, Disorders of calcium metabolism[HYPERCALCAEMIA]

+∞

35.5

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

6.6

35.3

A04

ICPC

Weakness/tiredness general

1.9

35.3

496

2782

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.8

35.2

188

705

XF600

NOMESCO Finland

Bloodpressure measurement

2.5

35.2

228

942

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.9

35.0

529

3038

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.1

34.7

380

1953

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.0

34.7

440

2384

SPAT1255

SPAT

Intravenous administration of medicine

2.3

34.6

264

1174

A28

ICPC

Limited function/disability NOS

1.8

34.3

564

3323

BBA70

NOMESCO Finland

Implantation or transplantation of parathyroid gland

42.4

34.0

C10AA05

ATC

atorvastatin; oral

1.6

34.0

1273

9306

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

33.7

1205

8711

KAT00

NOMESCO Finland

Extracorporeal shock wave lithotripsy of pelvis of kidney

5.7

33.5

110

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.7

33.4

180

678

N06AX11

ATC

mirtazapine; oral

1.6

33.3

1122

7997

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

2.4

33.2

236

1017

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

33.1

1043

7315

N05CF01

ATC

zopiclone; oral

1.6

32.9

1087

7708

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.1

32.8

143

480

E66.01

ICD-10 Finland

Obesity due to excess calories

2.2

32.5

275

1277

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

5.7

32.5

106

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

32.4

515

3000

SPAT1229

SPAT

Assessment of need for aid

2.2

32.2

289

1376

SPAT1216

SPAT

Assessment of functional ability

1.8

32.0

544

3233

B03BA03

ATC

hydroxocobalamin; parenteral

2.5

31.9

216

910

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

9.4

31.8

E87.2

ICD-10 Finland

Acidosis

166.5

31.7

C10AA01

ATC

simvastatin; oral

1.5

31.5

1259

9297

U14

ICPC

Kidney symptom/complaint

4.5

31.5

170

N20.9

ICD-10 Finland

Urinary calculus, unspecified

3.4

31.4

113

337

D70.82

ICD-10 Finland

Drug-induced neutropenia

4.2

31.3

200

N20.1

ICD-10 Finland

Calculus of ureter

2.8

31.3

156

564

C07AB02

ATC

metoprolol; systemic

1.7

31.3

647

4065

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.5

31.1

211

890

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

3.4

30.9

111

331

J01FF01

ATC

clindamycin; systemic

1.6

30.9

904

6210

H02AB04

ATC

methylprednisolone; systemic

1.8

30.6

506

2978

212

Kela drug reimbursment

Gout

4.1

30.6

212

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.2

30.5

200

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.5

30.4

200

832

B01AC04

ATC

clopidogrel; oral

1.9

30.3

448

2547

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.4

30.1

218

947

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.2

30.1

275

1318

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

3.5

30.0

103

298

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

30.0

873

5984

RD210, ,

NOMESCO Finland

4.2

29.9

194

XX7CT

NOMESCO Finland

Radioiodine therapy of thydoid tissue

6.0

29.9

E66.00

ICD-10 Finland

Metabolic syndrome

2.6

29.8

180

718

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

5.3

29.8

115

A02BC05

ATC

esomeprazole; systemic

1.5

29.8

1349

10203

WX882

NOMESCO Finland

High dependency care

3.3

29.8

115

359

C07AG02

ATC

carvedilol; oral

2.4

29.5

209

899

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.1

29.3

299

1494

E05.2

ICD-10 Finland

Thyrotoxicosis with toxic multinodular goitre

5.0

29.3

128

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

6.2

29.2

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

4.2

29.2

189

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.8

29.2

247

C09AA02

ATC

enalapril; systemic

1.7

29.2

630

3999

N03AX12

ATC

[U] gabapentin; oral

1.7

29.2

556

3410

A06AH03

ATC

naloxegol; oral

4.3

29.1

177

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

3.4

29.0

105

315

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.9

29.0

389

2143

TGC00

NOMESCO Finland

Bronchial lavation

3.3

28.9

110

340

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.4

28.9

202

863

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

4.0

28.9

208

X59

ICD-10 Finland

Exposure to unspecified factor

1.7

28.8

630

4011

A10BA02

ATC

metformin; oral

1.6

28.5

867

5992

A02BC01

ATC

omeprazole; systemic

1.6

28.5

909

6352

ZXE00

NOMESCO Finland

One hour or less

1.5

28.5

1258

9443

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

6.1

28.4

A10AE05

ATC

insulin detemir; parenteral

2.5

28.3

179

730

D86.2

ICD-10 Finland

Sarcoidosis of lung with sarcoidosis of lymph nodes

5.7

28.2

E20.0

ICD-10 Finland

Idiopathic hypoparathyroidism

55.5

28.1

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.7

28.1

639

4107

J01MA14

ATC

moxifloxacin; systemic

2.0

28.1

319

1658

TK820

NOMESCO Finland

Peritoneal dialysis

8.8

28.0

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.7

28.0

155

592

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

4.6

28.0

145

KBV00

NOMESCO Finland

Insertion of stent into ureter

7.5

28.0

WW300

NOMESCO Finland

Transfer of autologic stem cells

9.5

28.0

BBA50

NOMESCO Finland

Total parathyroidectomy

64.5

27.9

G72.8

ICD-10 Finland

Other specified myopathies

4.3

27.9

166

ZXA10

NOMESCO Finland

Bilateral

1.7

27.4

622

3993

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

8.3

27.4

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.2

27.4

242

1144

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

3.2

27.3

108

342

S97

ICPC

Chronic ulcer skin

2.3

27.3

213

956

E83.3

ICD-10 Finland

Disorders of phosphorus metabolism and phosphatases

+∞

27.1

I50.0

ICD-10 Finland

Congestive heart failure

2.2

27.1

225

1037

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.6

26.9

701

4659

L04AX01

ATC

azathioprine; systemic

2.6

26.8

163

653

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

7.5

26.7

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

6.9

26.7

R4110

NOMESCO Finland

Physiotherapy

1.6

26.7

877

6156

N16.2*D86.8

ICD-10 Finland

Renal tubulo-interstitial disorders in sarcoidosis

141.1

26.6

JN6AD

NOMESCO Finland

CT of torso and neck

3.7

26.6

235

L04AD01

ATC

ciclosporin; systemic

3.7

26.4

231

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.8

26.4

213

L03AA02

ATC

filgrastim; parenteral

2.9

26.4

129

462

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.0

26.3

284

1449

A46

ICD-10 Finland

Erysipelas

1.8

26.3

480

2902

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

26.3

1363

10524

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

8.4

26.1

E83.30

ICD-10 Finland

Acid phosphatase deficiency

+∞

26.1

ZXE20

NOMESCO Finland

More than three and less than five hours

1.8

26.0

444

2631

A10BB12

ATC

glimepiride; oral

2.2

26.0

216

995

I12.0

ICD-10 Finland

Hypertensive renal disease with renal failure

5.7

26.0

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.0

25.9

282

1442

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.5

25.9

165

676

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

25.8

1387

10776

E83.5

ICD-10 Finland

Disorders of calcium metabolism

262.5

25.7

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

25.6

1445

11324

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

6.4

25.6

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

22.0

25.6

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

3.8

25.6

204

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

25.4

868

6135

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

3.3

25.4

301

K65.0

ICD-10 Finland

Acute peritonitis

4.9

25.3

113

A41.8

ICD-10 Finland

Other specified sepsis

3.7

25.3

215

A04AA02

ATC

granisetron; systemic, transdermal

2.1

25.1

244

1197

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

25.0

503

3121

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

4.2

25.0

163

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.7

25.0

502

3114

N06AX16

ATC

venlafaxine; oral

1.8

24.9

440

2633

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.7

24.9

576

3710

F10.25

ICD-10 Finland

Alcohol dependence continuous use

4.0

24.7

182

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

251.9

24.7

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

3.5

24.6

252

N08.2*D89.80

ICD-10 Finland

Immunoglobulin A (IgA) nephropathy

7.3

24.6

E66.8

ICD-10 Finland

Other obesity

2.4

24.6

168

711

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.8

24.6

425

2527

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.7

24.5

133

503

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

24.5

358

2023

E21.5

ICD-10 Finland

Disorder of parathyroid gland, unspecified

27.7

24.4

KBV10

NOMESCO Finland

Removal of stent from ureter

5.6

24.4

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

4.0

24.4

175

M10.3

ICD-10 Finland

Gout due to impairment of renal function

8.9

24.2

NF1AA

NOMESCO Finland

Hip X-ray examination

1.9

24.0

314

1711

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

5.1

24.0

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

23.9

446

2709

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.8

23.9

118

425

NJ3DA

NOMESCO Finland

Long bones of extremities X-ray examination

7.5

23.7

H02AB07

ATC

prednisone; oral

1.7

23.7

457

2800

K92.1

ICD-10 Finland

Melaena

2.3

23.6

182

813

ZX112

NOMESCO Finland

Subcutaneous

3.2

23.5

300

A12BA01

ATC

potassium chloride; oral

2.5

23.5

148

603

WX002

NOMESCO Finland

Sedation and analgesia

1.6

23.5

628

4188

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.0

23.4

281

1488

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

2.9

23.4

112

397

SPAT1234

SPAT

Support of social functional capacity

2.3

23.3

178

791

P01AB01

ATC

metronidazole; oral, rectal

1.5

23.3

1264

9785

JDB10

NOMESCO Finland

Percutaneous gastrostomy

4.3

23.0

143

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

23.0

578

3794

A07AA09

ATC

vancomycin; oral

4.1

22.9

152

K08.3

ICD-10 Finland

Retained dental root

2.0

22.8

259

1344

N30.0

ICD-10 Finland

Acute cystitis

1.7

22.7

499

3165

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.1

22.7

224

1104

KAE12

NOMESCO Finland

Retrograde ureteronephroscopic lithotripsy in pelvis of kidney

6.3

22.7

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

20.8

22.5

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

22.4

448

2770

G47.3

ICD-10 Finland

Sleep apnoea

1.6

22.4

696

4800

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.9

22.4

292

1589

L95

ICPC

Osteoporosis

2.5

22.4

148

617

E04.9

ICD-10 Finland

Nontoxic goitre, unspecified

3.1

22.3

299

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.0

22.3

239

1216

E0000UV, ,

ATC

1.4

22.2

1324

10403

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

4.6

22.2

114

UJF30

NOMESCO Finland

Ileoscopy through colon

1.8

22.1

340

1950

E34.9

ICD-10 Finland

Endocrine disorder, unspecified

9.1

22.1

WX872

NOMESCO Finland

Intensive care

2.3

22.1

162

708

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.9

22.1

285

1546

C08CA02

ATC

felodipine; oral

1.9

21.8

303

1683

WF004

NOMESCO Finland

Palliative radiotherapy

3.1

21.8

309

Z2446

NOMESCO Finland

Social worker

2.1

21.7

215

1062

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

3.1

21.7

289

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

3.4

21.6

234

SPAT1310

SPAT

Counselling related to known health issue

1.5

21.6

1022

7686

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

21.5

641

4376

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

21.4

2312

20108

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.1

21.3

207

1014

Z31.5

ICD-10 Finland

Genetic counselling

2.2

21.3

176

809

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

19.0

21.2

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

20.8

21.2

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

4.0

21.2

148

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.0

21.1

309

R55

ICD-10 Finland

Syncope and collapse

1.8

21.0

331

1912

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

4.2

20.9

132

R79.0

ICD-10 Finland

Abnormal level of blood mineral

28.2

20.9

E83.8

ICD-10 Finland

Other disorders of mineral metabolism

+∞

20.8

M80.8

ICD-10 Finland

Other osteoporosis with pathological fracture

7.1

20.8

NHQ40

NOMESCO Finland

Amputation of toe

4.1

20.7

142

AN1

Coronary angiography

1.9

20.6

289

1610

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

20.5

1653

13629

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

4.6

20.5

105

L89

ICD-10 Finland

Decubitus ulcer and pressure area

3.4

20.5

212

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

3.1

20.4

273

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.3

20.4

161

726

N06AX21

ATC

duloxetine; oral

1.7

20.3

366

2197

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

20.3

903

6695

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.3

20.3

155

690

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

4.2

20.2

127

R60.0

ICD-10 Finland

Localized oedema

1.7

20.2

379

2302

N03AX14

ATC

levetiracetam; systemic

2.9

20.1

340

M54.5

ICD-10 Finland

Low back pain

1.4

20.1

1102

8495

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.7

19.9

417

2607

M81.8

ICD-10 Finland

Other osteoporosis

4.4

19.9

116

N18

ICD-10 Finland

Chronic kidney disease

4.6

19.8

104

R13

ICD-10 Finland

Dysphagia

2.0

19.8

231

1210

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.1

19.8

190

927

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.6

19.7

464

2991

UJF92

NOMESCO Finland

Capsular endoscopy

3.1

19.7

274

K70.1

ICD-10 Finland

Alcoholic hepatitis

6.4

19.6

H02AA02

ATC

fludrocortisone; oral

5.6

19.6

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.2

19.6

254

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

3.6

19.6

180

C01DA14

ATC

isosorbide mononitrate; oral

1.7

19.6

389

2399

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

6.6

19.6

197

Kela drug reimbursment

Sunitinib

7.8

19.5

R33

ICD-10 Finland

Retention of urine

1.9

19.4

237

1262

F10.24

ICD-10 Finland

Alcohol depence active use

3.9

19.4

149

R31

ICD-10 Finland

Unspecified haematuria

1.8

19.3

309

1791

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

19.3

543

3650

M81.0

ICD-10 Finland

Postmenopausal osteoporosis

2.6

19.2

114

452

Z3226

NOMESCO Finland

Physiotherapist

1.6

19.1

552

3733

A10BH01

ATC

sitagliptin; oral

1.8

19.0

284

1613

D86.1

ICD-10 Finland

Sarcoidosis of lymph nodes

5.7

19.0

R60.9

ICD-10 Finland

Oedema, unspecified

2.1

18.9

176

849

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.1

18.9

180

876

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.5

18.8

119

486

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.9

18.8

267

1492

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

18.7

569

3890

E03.89

ICD-10 Finland

Other specified hypothyroidism

2.4

18.7

128

543

SPAT1172

SPAT

Guidance concerning hydration

3.0

18.5

263

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.6

18.4

104

402

132

Kela drug reimbursment

Sarcoidosis

5.3

18.4

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.6

18.3

103

398

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

4.7

18.2

E89.00

ICD-10 Finland

Postirradiation hypothyroidism

19.4

18.2

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

4.0

18.1

125

K92.0

ICD-10 Finland

Haematemesis

2.9

18.0

299

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

4.4

18.0

100

SPAT1301

SPAT

No procedures

1.4

18.0

983

7543

T99

ICPC

Endocr/metab/nutrit disease other

3.4

17.9

186

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.7

17.9

318

1900

M13.9

ICD-10 Finland

Arthritis, unspecified

1.9

17.9

238

1303

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

17.8

1231

9824

R42

ICD-10 Finland

Dizziness and giddiness

1.5

17.8

681

4883

F05.9

ICD-10 Finland

Delirium, unspecified

3.1

17.8

232

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.0

17.8

185

931

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

3.0

17.7

259

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.7

17.7

387

2445

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.9

17.7

242

1337

M10.0

ICD-10 Finland

Idiopathic gout

2.5

17.6

110

447

N05AH04

ATC

quetiapine; oral

1.6

17.6

513

3472

3AC01, ,

NOMESCO Finland

4.4

17.5

XF402

NOMESCO Finland

ECG with work load test

1.8

17.4

294

1731

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

3.5

17.4

175

XCK10

NOMESCO Finland

Photography of fundus of eye

1.8

17.4

289

1694

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

17.0

17.4

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

3.9

17.3

129

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

17.3

913

6953

B99

ICD-10 Finland

Other and unspecified infectious diseases

3.1

17.3

226

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

2.8

17.3

312

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

17.2

916

6987

TKC20

NOMESCO Finland

Catheterisation of bladder

1.9

17.2

207

1097

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

3.8

17.1

139

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

4.1

17.1

117

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

17.1

539

3712

EP1DS

NOMESCO Finland

PET-MRI of neck metabolism

31.6

17.0

JAH00

NOMESCO Finland

Laparotomy

2.6

17.0

389

GD2SN

NOMESCO Finland

Lung ventilation SPECT

5.3

17.0

M79.6

ICD-10 Finland

Pain in limb

1.4

17.0

1285

10387

N07BB01

ATC

disulfiram; oral

2.3

17.0

130

579

Z71.8

ICD-10 Finland

Other specified counselling

1.4

17.0

892

6784

E87.8

ICD-10 Finland

Other disorders of electrolyte and fluid balance, not elsewhere classified

50.2

17.0

K70.4

ICD-10 Finland

Alcoholic hepatic failure

7.5

17.0

A02BC03

ATC

lansoprazole; oral

1.4

16.9

895

6816

105

Kela drug reimbursment

Adrenal cortical hypofunction

25.7

16.9

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

3.5

16.9

164

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

3.0

16.9

245

C08DB01

ATC

diltiazem; oral

2.1

16.9

159

771

WX730

NOMESCO Finland

Conventional respirator

3.6

16.9

150

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

6.1

16.8

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

4.4

16.8

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.4

16.8

111

463

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

5.4

16.8

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

3.9

16.8

123

A01

ICPC

Pain general/multiple sites

1.8

16.8

282

1658

L04AA01

ATC

[U] ciclosporin

3.5

16.8

160

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

6.3

16.7

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.9

16.7

222

1215

K59.09

ICD-10 Finland

Constipation, unspecified

1.9

16.6

203

1080

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

3.4

16.5

176

PC5DE

NOMESCO Finland

Ultrasound of kidney circulation with Doppler technic

7.0

16.5

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

3.3

16.5

186

N06AB04

ATC

citalopram; systemic

1.5

16.5

621

4432

N18.3

ICD-10 Finland

Chronic kidney disease, stage 3

4.2

16.5

107

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.2

16.5

144

678

ZXA00

NOMESCO Finland

Right side

1.4

16.4

812

6103

ED1AA

NOMESCO Finland

Mandibular X-ray examination

5.0

16.4

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

16.4

648

4671

KBE12

NOMESCO Finland

Transluminal endoscopic extraction of calculus of ureter

3.7

16.4

139

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.5

16.3

105

433

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.5

16.3

627

4493

C09AA05

ATC

ramipril; oral

1.5

16.3

715

5256

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.1

16.3

213

N06AB10

ATC

escitalopram; oral

1.5

16.3

572

4026

K76.9

ICD-10 Finland

Liver disease, unspecified

3.4

16.3

178

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.3

16.3

121

533

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.9

16.2

224

1241

B28

ICPC

Limited function/disability (B)

6.5

16.2

M10

ICD-10 Finland

Gout

2.2

16.2

139

650

R03AC02

ATC

salbutamol; inhalant

1.3

16.1

1705

14468

B01AF02

ATC

apixaban; oral

1.6

16.1

369

2356

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.2

16.0

142

672

JN5AQ

NOMESCO Finland

SPECT of thyroid metastasis with low-dose CT

24.6

16.0

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.3

16.0

118

518

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

15.9

309

1890

SPAT1211

SPAT

Application of soft bandage

1.7

15.9

280

1667

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

15.9

563

3967

R06AE07

ATC

cetirizine; oral

1.4

15.9

1345

11033

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

2.1

15.9

159

789

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

14.5

15.8

A10AB04

ATC

insulin lispro; parenteral

2.7

15.8

327

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.3

15.7

120

534

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

15.7

1193

9618

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.2

15.7

129

592

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.3

15.7

116

509

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.6

15.7

351

H3603, E103,

ICD-10 Finland

5.5

15.7

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.0

15.7

162

813

Z94.4

ICD-10 Finland

Liver transplant status

6.9

15.7

C73

ICD-10 Finland

Malignant neoplasm of thyroid gland

6.9

15.7

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

4.5

15.6

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

3.8

15.6

125

C09CA01

ATC

losartan; oral

1.4

15.6

799

6035

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

3.5

15.6

158

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.2

15.6

138

653

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.9

15.6

207

1133

L17

ICPC

Foot/toe symptom/complaint

1.4

15.5

865

6632

124

Kela drug reimbursment

Inborn metabolic disorders

160.7

15.5

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

4.4

15.4

N05CD07

ATC

temazepam; oral

1.6

15.4

353

2256

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

3.6

15.3

141

AA1AA

NOMESCO Finland

Head X-ray examination

4.2

15.3

R80

ICD-10 Finland

Isolated proteinuria

5.0

15.2

SPAT1167

SPAT

Insertion of urinary catheter

2.5

15.2

387

B81

ICPC

Anaemia vit B12/folate deficiency

2.2

15.1

122

556

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

3.8

15.1

119

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.9

15.1

184

979

B01AA03

ATC

warfarin; systemic

1.5

15.1

542

3828

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.7

15.0

257

1519

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

14.9

783

5935

KA3EB

NOMESCO Finland

Antegrade pyelography

5.8

14.9

A10AD05

ATC

insulin aspart; parenteral

3.3

14.9

173

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.8

14.9

213

1194

WX725

NOMESCO Finland

Noninvasive ventilation

2.0

14.8

168

872

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.3

14.8

110

485

GD1UN

NOMESCO Finland

Lung circulation SPECT

5.5

14.8

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.8

14.7

210

1175

WVA20

NOMESCO Finland

Medicine administration

2.6

14.7

316

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

13.2

14.7

E20.1

ICD-10 Finland

Pseudohypoparathyroidism

+∞

14.6

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.0

14.6

170

891

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.7

14.6

306

JN4CD

NOMESCO Finland

Very extensive body CT

2.2

14.6

127

598

R5140

NOMESCO Finland

Monitoring the use of the aid

1.6

14.5

323

2046

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

14.5

294

1818

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

4.3

14.5

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.8

14.5

224

1284

D70.89

ICD-10 Finland

Neutropenic splenomegaly

3.5

14.5

146

192

Kela drug reimbursment

Fulvestrant

5.0

14.5

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.8

14.4

214

1212

C10AA04

ATC

fluvastatin; oral

1.8

14.4

219

1250

XKD00

NOMESCO Finland

Uroflowmetry

1.5

14.4

475

3294

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

3.2

14.3

172

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.2

14.3

116

530

TPX15

NOMESCO Finland

Removal of vascular injection port

6.0

14.3

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.0

14.3

214

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

5.5

14.3

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

3.5

14.3

138

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

3.2

14.2

178

JFB00

NOMESCO Finland

Partial resection of small intestine

3.2

14.2

178

XPX08

NOMESCO Finland

Intraoperative flow measurement

4.7

14.2

SPAT1260

SPAT

Consultation of another employee

1.5

14.2

533

3793

A07AA02

ATC

nystatin; oral

1.9

14.2

189

1035

XG410

NOMESCO Finland

Flow-volume spirometry

2.1

14.2

127

604

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.7

14.2

257

1544

A02BA02

ATC

ranitidine; systemic

1.5

14.1

578

4183

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.1

14.1

126

599

ZYC01

NOMESCO Finland

Remote contact by phone

1.9

14.1

175

937

E89.09

ICD-10 Finland

Postprocedural hypothyroidism, other or several procedures

42.7

14.1

ZX121

NOMESCO Finland

Central venous catheter

6.4

14.1

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.0

14.1

147

741

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

2.2

14.1

122

573

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.0

14.0

159

826

SPAT1097

SPAT

Recording of ECG

1.5

14.0

438

3003

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

14.0

263

1595

A10AB01

ATC

insulin (human); parenteral

2.5

14.0

366

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.0

13.9

142

710

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

3.1

13.9

191

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

2.8

13.9

245

EBA10

NOMESCO Finland

Operative extraction of tooth

1.6

13.9

337

2182

T89

ICPC

Diabetes insulin dependent

2.3

13.8

107

480

C09BA02

ATC

enalapril and diuretics; systemic

1.7

13.8

236

1394

WX202

NOMESCO Finland

Supraclavicular plexus blockade

3.1

13.7

182

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

13.7

557

4026

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

5.7

13.7

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

13.7

212

1218

PB1DE

NOMESCO Finland

Upper extremity arteries ultrasound examination with Doppler method

6.5

13.6

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.8

13.6

192

1071

C07AA05

ATC

propranolol; systemic

1.4

13.6

587

4288

PG1XE

NOMESCO Finland

Other ultrasound examination of blood vessel not elsewhere classified

5.1

13.6

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.1

13.6

122

581

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

3.0

13.5

194

ZYC06

NOMESCO Finland

Real-time text-based remote transaction

10.9

13.5

ZXA05

NOMESCO Finland

Left side

1.4

13.5

729

5543

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

4.1

13.5

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

2.2

13.5

108

492

C75.0

ICD-10 Finland

Malignant neoplasm: Parathyroid gland

140.5

13.5

A10AE06

ATC

insulin degludec; parenteral

2.4

13.4

385

L03AA13

ATC

pegfilgrastim; parenteral

2.0

13.4

148

761

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

5.2

13.4

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.2

13.4

110

506

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

13.4

377

2526

PG5AC

NOMESCO Finland

Contrast examination of injection gate to artery or vein

25.8

13.4

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

2.8

13.3

245

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

4.4

13.3

SPAT1104

SPAT

Monitoring of emergency patient

1.8

13.3

203

1160

9680/3-C77.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph node, NOS

6.3

13.3

M81.5

ICD-10 Finland

Idiopathic osteoporosis

4.1

13.3

J01CA04

ATC

amoxicillin; systemic

1.3

13.3

2653

24332

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.3

13.3

145

R20.2

ICD-10 Finland

Paraesthesia of skin

1.8

13.2

196

1110

KAC10

NOMESCO Finland

Total nephrectomy with capsule

4.1

13.2

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

4.2

13.1

R41.0

ICD-10 Finland

Disorientation, unspecified

2.4

13.1

377

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

3.1

13.1

182

B04

ICPC

Blood symptom/complaint

4.8

13.1

394

Kela drug reimbursment

Palbociclib

4.6

13.0

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

3.7

13.0

113

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

13.0

416

2866

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.9

12.9

164

885

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

6.1

12.9

N11.8

ICD-10 Finland

Other chronic tubulo-interstitial nephritis

22.6

12.9

R52.9

ICD-10 Finland

Pain, unspecified

1.6

12.9

279

1756

1501

Kela drug reimbursment

Palbociclib

4.5

12.8

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.7

12.8

221

1309

I81

ICD-10 Finland

Portal vein thrombosis

5.8

12.7

S18

ICPC

Laceration/cut

1.3

12.7

1426

12064

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.8

12.7

198

1139

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

3.9

12.7

SPAT1240

SPAT

Therapeutic discussion

1.6

12.7

276

1739

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.7

12.6

239

1452

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

4.8

12.6

5BA08, ,

NOMESCO Finland

4.8

12.6

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

6.0

12.6

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.2

12.5

103

474

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.5

12.5

318

E87.3

ICD-10 Finland

Alkalosis

+∞

12.5

JFF13

NOMESCO Finland

Terminal enterostomy

11.0

12.5

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

12.5

799

6236

D44.8

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement

24.4

12.5

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

1.9

12.5

159

860

J94.8

ICD-10 Finland

Other specified pleural conditions

2.9

12.4

193

D07AA02

ATC

hydrocortisone; topical

1.5

12.4

392

2690

WX704

NOMESCO Finland

Intubation

1.7

12.4

228

1374

A12AA12

ATC

[U] calcium acetate

13.2

12.4

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.3

12.4

419

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

4.0

12.4

J01CA08

ATC

pivmecillinam; oral

1.3

12.3

1179

9750

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

2.9

12.3

205

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.8

12.3

222

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.2

12.2

440

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

3.1

12.2

163

A07AA11

ATC

rifaximin; oral

9.0

12.2

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.8

12.2

177

997

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

3.7

12.2

104

A05AA02

ATC

ursodeoxycholic acid; oral

2.8

12.2

212

A79

ICPC

Malignancy NOS

2.9

12.2

201

N20.2

ICD-10 Finland

Calculus of kidney with calculus of ureter

4.4

12.1

N06AX26

ATC

vortioxetine; oral

1.8

12.1

188

1080

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.9

12.1

165

911

K91.2

ICD-10 Finland

Postsurgical malabsorption, not elsewhere classified

15.9

12.1

KBT00

NOMESCO Finland

Extracorporeal shock wave lithotripsy of ureter

6.0

12.1

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.2

12.1

105

494

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.5

12.1

299

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

12.1

359

2431

L02BA03

ATC

fulvestrant; parenteral

4.1

12.1

J01EA01

ATC

trimethoprim; systemic

1.4

12.1

757

5882

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

5.2

12.0

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.8

12.0

184

1055

NF3AA

NOMESCO Finland

Femur X-ray examination

2.5

11.9

295

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.3

11.9

381

F50.9

ICD-10 Finland

Eating disorder, unspecified

4.3

11.9

G04CA02

ATC

tamsulosin; oral

1.4

11.9

649

4931

R10.0

ICD-10 Finland

Acute abdomen

2.2

11.9

439

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.3

11.9

407

J02AC01

ATC

fluconazole; systemic

1.3

11.9

1140

9422

C10AC01

ATC

colestyramine; oral

2.3

11.9

388

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.7

11.8

215

1292

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.2

11.8

421

R03BB04

ATC

tiotropium bromide; inhalant

1.6

11.7

290

1886

A04.9

ICD-10 Finland

Bacterial intestinal infection, unspecified

4.4

11.7

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.7

11.7

203

1206

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

11.7

943

7608

N02BF01

ATC

gabapentin; oral

1.7

11.7

232

1429

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

4.5

11.7

2520A

ICD-9 Finland

Disorders of parathyroid gland, Hyperparathyroidism

30.1

11.6

L01XE04

ATC

[U] sunitinib

12.6

11.6

K29.8

ICD-10 Finland

Duodenitis

4.1

11.6

2522

FHL

Removal of parathyroidism or multiple parathyroidism (including removal of adenoma or total removal)

23.0

11.6

WX722

NOMESCO Finland

PEEP

1.9

11.5

136

717

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

2.8

11.5

196

A10BH02

ATC

vildagliptin; oral

2.7

11.5

224

N05BA06

ATC

lorazepam; systemic, sublingual

1.9

11.5

152

832

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

4.3

11.5

2754B

ICD-9 Finland

Disorders of mineral metabolism, Disorders of calcium metabolism[HYPERCALCURIA]

+∞

11.5

ZX095

NOMESCO Finland

Combined chemoradiotherapy

4.0

11.5

K86.1

ICD-10 Finland

Other chronic pancreatitis

3.8

11.5

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

11.4

224

1374

ZY010

NOMESCO Finland

Hospital outpatient

1.9

11.4

136

719

E31.00

ICD-10 Finland

APECED syndrome

120.4

11.4

C08CA05

ATC

nifedipine; systemic

1.8

11.4

172

980

R52.2

ICD-10 Finland

Other chronic pain

2.1

11.4

109

533

J01CF05

ATC

flucloxacillin; systemic

1.8

11.4

173

988

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

11.3

1326

11232

R07.3

ICD-10 Finland

Other chest pain

1.6

11.3

280

1820

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

15.1

11.3

G72.9

ICD-10 Finland

Myopathy, unspecified

3.9

11.3

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.2

11.3

423

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

3.1

11.2

145

K65.9

ICD-10 Finland

Peritonitis, unspecified

10.6

11.2

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.6

11.2

261

1671

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.5

11.2

338

2297

N03AX09

ATC

lamotrigine; oral

2.0

11.2

121

619

K06.18

ICD-10 Finland

Another gingival hyperplasia

5.6

11.2

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

5.6

11.2

E46

ICD-10 Finland

Unspecified protein-energy malnutrition

25.1

11.1

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.8

11.1

182

1063

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.1

11.1

472

D64.8

ICD-10 Finland

Other specified anaemias

2.8

11.1

195

NGQ20

NOMESCO Finland

Amputation of lower leg

5.3

11.1

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.6

11.0

235

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

2.8

11.0

201

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

4.3

11.0

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.7

11.0

206

1249

Z01.9

ICD-10 Finland

Special examination, unspecified

1.8

11.0

177

1029

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.8

11.0

157

881

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

4.4

11.0

R63.4

ICD-10 Finland

Abnormal weight loss

2.0

11.0

117

596

PBM10

NOMESCO Finland

Closure of arteriovenous fistula of radial artery

13.9

11.0

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.0

11.0

120

617

TGD00

NOMESCO Finland

Needle biopsy of lung

4.8

10.9

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

4.5

10.9

SPAT1153

SPAT

Removal of sutures

1.3

10.9

987

8073

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.0

10.9

117

597

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

3.8

10.9

BB1AN

NOMESCO Finland

Parathyroid gland isotope imaging, 1 isotope

43.4

10.9

M84.3

ICD-10 Finland

Stress fracture, not elsewhere classified

3.0

10.9

153

D10

ICPC

Vomiting

1.9

10.9

141

767

M79.7

ICD-10 Finland

Fibromyalgia

2.1

10.9

456

E27.1

ICD-10 Finland

Primary adrenocortical insufficiency

11.9

10.8

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

3.4

10.8

113

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

3.4

10.8

113

A10AD01

ATC

insulin (human); parenteral

2.9

10.8

170

N05BA01

ATC

diazepam; systemic, rectal

1.5

10.8

371

2590

R51.80

ICD-10 Finland

Headache

1.5

10.8

410

2919

N02BF02

ATC

pregabalin; oral

1.8

10.8

164

938

Z3229

NOMESCO Finland

Other healthcare associate professional

1.6

10.8

239

1514

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.3

10.8

354

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

10.7

1126

9389

160

Kela drug reimbursment

exenatide

2.7

10.7

204

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

2.0

10.7

122

636

C09CA06

ATC

candesartan; oral

1.4

10.7

682

5304

I50

ICD-10 Finland

Heart failure

2.3

10.7

355

C09CA03

ATC

valsartan; oral

1.6

10.7

269

1756

Y84

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.4

10.7

109

ZX070

NOMESCO Finland

Intensity modified radiotherapy

2.5

10.6

263

A10AA01, ,

ATC

2.6

10.6

234

N05BA02

ATC

chlordiazepoxide; systemic

2.3

10.6

331

M48.0

ICD-10 Finland

Spinal stenosis

1.5

10.6

356

2474

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.8

10.6

183

N30.9

ICD-10 Finland

Cystitis, unspecified

1.8

10.6

169

981

J01DA01

ATC

[U] cefalexin

1.3

10.6

1899

16898

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

10.5

1396

11978

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.2

10.5

422

D50.8

ICD-10 Finland

Other iron deficiency anaemias

3.0

10.5

151

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.4

10.5

295

R74.0

ICD-10 Finland

Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]

2.6

10.5

241

1502

Kela drug reimbursment

Cabozantinib

9.2

10.5

3012

Kela drug reimbursment

Cabozantinib

9.2

10.5

SAA04

NOMESCO Finland

Special examination of mouth

1.8

10.5

158

901

I25.2

ICD-10 Finland

Old myocardial infarction

1.8

10.5

143

791

K90.3

ICD-10 Finland

Pancreatic steatorrhoea

4.5

10.5

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

2.6

10.5

224

R02

ICPC

Shortness of breath/dyspnoea

1.5

10.4

358

2498

E85.9

ICD-10 Finland

Amyloidosis, unspecified

110.3

10.4

B05XA09

ATC

sodium phosphate; parenteral

+∞

10.4

2753A

ICD-9 Finland

Disorders of mineral metabolism, Disorders of phosphorus metabolism[HYPOPHOSPHATHAEMIA FAMILIARIS]

+∞

10.4

E55.0

ICD-10 Finland

Rickets, active

+∞

10.4

UKA02

NOMESCO Finland

Retrograde ureteronephroscopy

5.4

10.4

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

3.2

10.4

121

L01CA04

ATC

vinorelbine; systemic

3.3

10.4

116

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.3

10.4

347

M25.5

ICD-10 Finland

Pain in joint

1.3

10.4

930

7591

B07.9

ICD-10 Finland

Verruca simplex

2.0

10.3

104

519

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

3.5

10.3

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.8

10.3

167

973

SPAT1312

SPAT

General health counselling

1.3

10.3

938

7670

G41.9

ICD-10 Finland

Status epilepticus, unspecified

5.1

10.3

OAB50, ,

SPAT

1.8

10.3

158

906

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

3.8

10.3

K70.0

ICD-10 Finland

Alcoholic fatty liver

3.8

10.3

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

10.3

360

2521

ZY000

NOMESCO Finland

Hospital inpatient

3.1

10.3

132

K59.1

ICD-10 Finland

Functional diarrhoea

1.8

10.3

157

899

R5110, ,

SPAT

1.7

10.3

182

1087

C02EA02, ,

ATC

2.0

10.3

116

603

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

10.3

467

3434

K72.9

ICD-10 Finland

Hepatic failure, unspecified

4.4

10.3

WX199

NOMESCO Finland

Other local analgesia

2.1

10.2

488

I95.9

ICD-10 Finland

Hypotension, unspecified

2.9

10.2

154

C10AB05

ATC

fenofibrate; oral

2.8

10.2

176

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.9

10.1

129

698

E04.0

ICD-10 Finland

Nontoxic diffuse goitre

3.7

10.1

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

5.3

10.1

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

2.1

10.1

483

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.1

10.1

470

H25.8

ICD-10 Finland

Other senile cataract

1.5

10.1

325

2240

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

5.0

10.0

PE1YT

NOMESCO Finland

Femoral or popliteal artery PTA with stent

3.8

10.0

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.6

10.0

228

1453

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

4.5

10.0

M80.5

ICD-10 Finland

Idiopathic osteoporosis with pathological fracture

4.5

10.0

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

4.8

10.0

N11.9

ICD-10 Finland

Chronic tubulo-interstitial nephritis, unspecified

9.1

10.0

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.6

10.0

257

1686

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

3.3

10.0

109

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.8

9.9

160

931

SPAT1325

SPAT

Vaccination

1.3

9.9

999

8272

J01AA02

ATC

doxycycline; systemic

1.3

9.9

2512

23196

XF404

NOMESCO Finland

Ambulatory ECG

1.6

9.9

234

1507

EBA00

NOMESCO Finland

Extraction of tooth

1.3

9.8

1027

8542

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

2.2

9.8

362

K59.0

ICD-10 Finland

Constipation

1.8

9.8

152

875

TAB00

NOMESCO Finland

Lumbar puncture

1.9

9.8

130

714

SPAT1279

SPAT

Preparation of immediate hospitalisation

3.4

9.7

101

K83.1

ICD-10 Finland

Obstruction of bile duct

2.7

9.7

192

N05CF02

ATC

zolpidem; oral

1.4

9.7

491

3677

WZA10

NOMESCO Finland

Extensive medical or dental certificate

2.9

9.7

153

Z93.2

ICD-10 Finland

Ileostomy status

5.3

9.6

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.9

9.6

123

668

A29

ICPC

General symptom/complaint other

1.5

9.6

351

2480

KH1AA

NOMESCO Finland

Urinary tract X-ray examination without contrast

2.8

9.5

160

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

4.6

9.5

Z02.7

ICD-10 Finland

Issue of medical certificate

1.7

9.5

188

1157

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

9.5

1656

14615

B80

ICPC

Iron deficiency anaemia

2.3

9.4

291

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

2.7

9.4

189

E21.4

ICD-10 Finland

Other specified disorders of parathyroid gland

100.3

9.4

BBA99

NOMESCO Finland

Other operations on parathyroid gland

100.3

9.4

M14.5

ICD-10 Finland

Arthropathies in other endocrine, nutritional and metabolic disorders

+∞

9.4

E89.1

ICD-10 Finland

Postprocedural hypoinsulinaemia

+∞

9.4

2750A

ICD-9 Finland

Disorders of mineral metabolism, Disorders of iron metabolism[HAEMOCHROMATOSIS]

+∞

9.4

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

3.6

9.4

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.4

9.4

255

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

5.2

9.4

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.6

9.3

213

1359

B37.08

ICD-10 Finland

Other candidal stomatitis

3.4

9.3

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

3.2

9.3

114

P15

ICPC

Chronic alcohol abuse

2.2

9.3

370

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.6

9.3

202

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

4.9

9.3

FM1LE

NOMESCO Finland

Combined ultrasound and EKG examination of heart with tolerance test

4.9

9.3

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

4.9

9.3

WX720

NOMESCO Finland

Own respiration

1.8

9.3

128

711

N06AB06

ATC

sertraline; oral

1.5

9.3

300

2067

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

4.7

9.3

D86

ICD-10 Finland

Sarcoidosis

8.7

9.3

E03.80

ICD-10 Finland

Hypothyroidism caused by autoimmune thyroiditis

2.5

9.3

238

B74

ICPC

Malignant neoplasm blood other

10.7

9.3

YNB10

NOMESCO Finland

Collection of stem cells for transplant

10.7

9.3

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

2.5

9.3

226

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

2.9

9.3

146

1507

Kela drug reimbursment

Pomalidomide

9.5

9.3

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.2

9.2

371

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.6

9.2

218

1402

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.2

9.2

345

R79.8

ICD-10 Finland

Other specified abnormal findings of blood chemistry

4.1

9.2

W19

ICD-10 Finland

Unspecified fall

1.5

9.2

269

1815

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.8

9.2

141

809

SBB10

NOMESCO Finland

Dental impressions

1.7

9.2

184

1136

H3600, E113,

ICD-10 Finland

3.1

9.2

120

XG466

NOMESCO Finland

Sleep oxymetry

2.1

9.2

432

SPAT1252

SPAT

Overall medication plan or its review

1.6

9.1

188

1169

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

3.7

9.1

K55.0

ICD-10 Finland

Acute vascular disorders of intestine

3.9

9.1

S76

ICPC

Skin infection other

1.7

9.1

151

886

WPB10

NOMESCO Finland

Making a convalescent care decision

5.0

9.1

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.4

9.1

265

T29

ICPC

Endocr/metab/nutr sympt/compl other

2.4

9.1

259

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.5

9.1

279

1904

207

Kela drug reimbursment

Chronic arrhythmias

1.4

9.1

424

3132

M81.4

ICD-10 Finland

Drug-induced osteoporosis

4.8

9.1

TJA33

NOMESCO Finland

Percutaneous introduction of peritoneal dialysis catheter

8.3

9.1

R18

ICD-10 Finland

Ascites

2.4

9.0

247

D63.8

ICD-10 Finland

Anaemia in other chronic diseases classified elsewhere

9.0

K07

ICPC

Swollen ankles/oedema

1.8

9.0

127

711

SPAT1125

SPAT

Stoma care and guidance

2.6

9.0

188

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.6

9.0

188

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

9.0

439

3266

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.1

9.0

402

S72.2

ICD-10 Finland

Subtrochanteric fracture

3.7

9.0

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.7

9.0

149

875

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

2.2

9.0

343

N06AA09

ATC

amitriptyline; systemic

1.5

9.0

272

1851

UJC01

NOMESCO Finland

Scopy of lower throat

3.1

8.9

117

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

3.0

8.9

133

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

3.1

8.9

112

S06.0

ICD-10 Finland

Concussion

1.5

8.9

285

1961

GBB00

NOMESCO Finland

Tracheostomy

2.9

8.9

144

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

1.6

8.9

199

1264

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

3.3

8.9

K20

ICD-10 Finland

Oesophagitis

2.5

8.9

225

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.5

8.9

219

K12.10

ICD-10 Finland

Stomatitis NOS

3.9

8.9

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

2.2

8.8

332

393

Kela drug reimbursment

Pomalidomide

8.0

8.8

C03BA11

ATC

indapamide; oral

2.1

8.8

378

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

4.9

8.8

Z50.1

ICD-10 Finland

Other physical therapy

1.7

8.8

150

887

K85.2

ICD-10 Finland

Alcohol-induced acute pancreatitis

4.5

8.8

S01.0

ICD-10 Finland

Open wound of scalp

1.6

8.8

217

1410

N39.1

ICD-10 Finland

Persistent proteinuria, unspecified

4.7

8.8

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.2

8.8

313

PE1BT

NOMESCO Finland

Femoral artery extensive PTA

4.0

8.8

R04.0

ICD-10 Finland

Epistaxis

1.6

8.8

209

1348

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.2

8.7

340

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

1.9

8.7

113

617

L03

ICPC

Low back symptom/complaint

1.3

8.7

774

6292

E20

ICD-10 Finland

Hypoparathyroidism

50.1

8.7

E87.7

ICD-10 Finland

Fluid overload

50.1

8.7

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.9

8.7

511

NFC20

NOMESCO Finland

Secondary implantation of hip prosthesis

2.4

8.7

246

Z29.9

ICD-10 Finland

Prophylactic measure, unspecified

3.3

8.6

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.8

8.6

120

670

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

2.7

8.6

158

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.8

8.6

133

766

101

Kela drug reimbursment

Anterior pituitary hypofunction

4.0

8.6

GD6AD

NOMESCO Finland

CT of chest and neck

4.6

8.6

L04AX06

ATC

pomalidomide; oral

8.2

8.6

Z83.4

ICD-10 Finland

Family history of other endocrine, nutritional and metabolic diseases

11.6

8.6

Z73.6

ICD-10 Finland

Limitation of activities due to disability

3.6

8.5

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.4

8.5

384

2816

V03AE04

ATC

calcium acetate and magnesium carbonate; systemic

16.3

8.5

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

8.5

307

2162

A10BJ02

ATC

liraglutide; parenteral

2.2

8.5

324

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

9.0

8.5

Z01.2

ICD-10 Finland

Dental examination

1.2

8.5

1314

11395

UKB02

NOMESCO Finland

Retrograde ureteroscopy

3.1

8.5

110

E05.80

ICD-10 Finland

Subacute thyrotoxicosis

3.5

8.5

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.8

8.5

114

629

168

Kela drug reimbursment

Axitinib

27.6

8.5

H05BX02

ATC

paricalcitol; systemic

20.1

8.5

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.0

8.4

453

WF099

NOMESCO Finland

Other radiotherapy

3.7

8.4

I20.09

ICD-10 Finland

Unstable angina

1.8

8.4

127

726

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.1

8.4

392

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

1.7

8.4

141

831

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

4.3

8.4

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.4

8.4

219

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.5

8.4

213

C07AB03

ATC

atenolol; systemic

1.7

8.4

155

939

7151

FHL

Kidney transplantation

12.8

8.4

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

4.5

8.4

TJD20

NOMESCO Finland

Change of gastrostomy tube

4.5

8.4

UDC00

NOMESCO Finland

Ear microscopy

1.6

8.3

212

1388

A10AB06

ATC

insulin glulisine; parenteral

3.2

8.3

2521A

ICD-9 Finland

Disorders of parathyroid gland, Hypoparathyroidism

+∞

8.3

N16.3

ICD-10 Finland

Renal tubulo-interstitial disorders in metabolic diseases

+∞

8.3

BB1AQ

NOMESCO Finland

Parathyroidgland SPECT with low dose CT

+∞

8.3

J01XX08

ATC

linezolid; systemic

3.8

8.3

L60.0

ICD-10 Finland

Ingrowing nail

1.8

8.3

123

699

NFQ20

NOMESCO Finland

Amputation of femur

4.0

8.3

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

2.4

8.3

232

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.5

8.3

225

1494

RS221, ,

NOMESCO Finland

2.7

8.3

161

A10BX07

ATC

[U] liraglutide

3.0

8.3

117

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

2.8

8.3

139

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

8.2

649

5186

N05AN01

ATC

lithium; oral

2.2

8.2

303

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.7

8.2

134

785

L40.0

ICD-10 Finland

Psoriasis vulgaris

1.8

8.2

117

659

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

3.0

8.1

113

J01MA06

ATC

norfloxacin; oral

1.4

8.1

367

2694

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.1

8.1

364

WVA30

NOMESCO Finland

Intramuscular and subcutaneous injection

4.8

8.1

25200

ICD-8 Finland

Diseases of parathyroid gland, Hyperparathyroidism

33.4

8.1

PB1AC

NOMESCO Finland

Angiography of upper extremity with X-ray

17.2

8.1

D72.8

ICD-10 Finland

Other specified disorders of white blood cells

3.2

8.1

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.0

8.1

440

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.8

8.0

110

611

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

1.6

8.0

167

1043

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

8.0

1315

11459

C10AA03

ATC

pravastatin; oral

1.6

8.0

168

1051

UJD02

NOMESCO Finland

Gastroscopy

1.8

8.0

126

730

WX2DD

NOMESCO Finland

Low-dose CT of skeleton in whole body

6.3

8.0

C02CA01

ATC

prazosin; oral

2.5

8.0

188

H04AA01

ATC

glucagon; nasal, parenteral

2.4

8.0

206

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

8.0

606

4818

L29.9

ICD-10 Finland

Pruritus, unspecified

2.1

8.0

360

H3600, E103,

ICD-10 Finland

3.5

8.0

K25.7

ICD-10 Finland

Gastric ulcer, Chronic without haemorrhage or perforation

2.9

8.0

120

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.3

8.0

769

6308

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

7.2

7.9

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

2.6

7.9

165

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.8

7.9

111

621

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.5

7.9

218

1453

M87.1

ICD-10 Finland

Osteonecrosis due to drugs

4.3

7.9

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.4

7.9

373

2758

QDB99

NOMESCO Finland

Other procedure for wound of skin of lower limb

4.4

7.9

C22.1

ICD-10 Finland

Malignant neoplasm: Intrahepatic bile duct carcinoma

4.4

7.9

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

7.9

760

6231

JCA22

NOMESCO Finland

Endoscopic ligature of oesophageal varices

6.6

7.9

K70.9

ICD-10 Finland

Alcoholic liver disease, unspecified

6.6

7.9

WX204

NOMESCO Finland

Axillary plexus blockaced

1.9

7.9

100

543

M05BA07

ATC

risedronic acid; oral

1.9

7.9

465

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.7

7.9

143

J01FA06

ATC

roxithromycin; oral

1.2

7.8

1169

10077

E66.0

ICD-10 Finland

Obesity due to excess calories

3.1

7.8

100

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.3

7.8

636

5103

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

3.2

7.8

C09CA07

ATC

telmisartan; oral

1.6

7.8

202

1329

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.1

7.8

323

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

2.9

7.8

127

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

10.8

7.8

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

3.3

7.8

ZX080

NOMESCO Finland

Image guided radiotherapy

2.1

7.8

350

R4130

NOMESCO Finland

Speech therapy

2.1

7.8

317

SXC03

NOMESCO Finland

Other oral or dental procedure

2.8

7.7

133

SPAT1238

SPAT

Brief therapy

2.5

7.7

179

N21.0

ICD-10 Finland

Calculus in bladder

3.0

7.7

106

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.4

7.7

369

2734

4CJ01, ,

NOMESCO Finland

15.0

7.7

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

6.4

7.7

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

1.9

7.7

100

547

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

3.5

7.7

C08CA10

ATC

nilvadipine; oral

2.3

7.7

241

D89.80

ICD-10 Finland

Immunoglobulin A (IgA) deposits in organisms

7.4

7.7

F05.8

ICD-10 Finland

Other delirium

3.4

7.7

N28.1

ICD-10 Finland

Cyst of kidney

2.5

7.7

174

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

2.0

7.6

393

K83.0

ICD-10 Finland

Cholangitis

2.5

7.6

192

JAH01

NOMESCO Finland

Laparoscopy

1.8

7.6

110

621

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.8

7.6

110

621

N06AB03

ATC

fluoxetine; oral

1.4

7.6

327

2379

I48.2

ICD-10 Finland

Chronic atrial fibrillation

1.8

7.6

107

600

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.1

7.6

313

TQW99

NOMESCO Finland

Other minor procedure on skin

1.7

7.6

139

840

N26

ICD-10 Finland

Unspecified contracted kidney

18.4

7.6

3XA02, ,

NOMESCO Finland

18.4

7.6

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

2.4

7.6

211

L01EX07

ATC

cabozantinib; oral

8.0

7.6

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

2.8

7.6

129

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.8

7.6

113

645

N25.0

ICD-10 Finland

Renal osteodystrophy

11.9

7.6

P01BA02

ATC

hydroxychloroquine; oral

1.5

7.6

231

1575

U05

ICPC

Urination problems other

1.7

7.6

137

826

L29.8

ICD-10 Finland

Other pruritus

2.7

7.5

152

M86.1

ICD-10 Finland

Other acute osteomyelitis

8.9

7.5

C09DA06

ATC

candesartan and diuretics; oral

1.5

7.5

206

1372

N18

ICPC

Paralysis/weakness

2.3

7.5

243

WX212

NOMESCO Finland

Femoral plexus blockade

2.1

7.5

321

SBB20

NOMESCO Finland

Tooth X-ray examination in conjunction with visit to dentist

2.8

7.5

124

N06AX12

ATC

bupropion; oral

1.6

7.5

162

1021

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

2.6

7.5

158

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.7

7.5

144

881

A03

ICPC

Fever

1.4

7.5

417

3166

M01AB01

ATC

indometacin; systemic, rectal

1.5

7.5

202

1341

E03

ICD-10 Finland

Other hypothyroidism

1.6

7.5

156

975

S70.0

ICD-10 Finland

Contusion of hip

1.8

7.5

106

596

G44.2

ICD-10 Finland

Tension-type headache

1.4

7.5

345

2542

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.4

7.5

335

2456

PA6BG

NOMESCO Finland

MRI examination of neck vasculature with high intensity magnet

3.7

7.5

R25.1

ICD-10 Finland

Tremor, unspecified

1.9

7.4

460

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

2.9

7.4

114

I12

ICD-10 Finland

Hypertensive renal disease

80.3

7.4

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.8

7.4

110

627

K02.1

ICD-10 Finland

Caries of dentine

1.2

7.4

1722

15504

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.2

7.4

290

WF002

NOMESCO Finland

Radical radiotherapy

1.6

7.4

156

978

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

2.5

7.4

189

N04BC05

ATC

pramipexole; oral

1.5

7.4

215

1451

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

2.2

7.4

258

WPA44

NOMESCO Finland

Nursing home for palliative care

13.4

7.4

BB1BN

NOMESCO Finland

Parathyroid gland isotope imaging, 2 isotopes

13.4

7.4

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.6

7.4

147

909

C10AX09

ATC

ezetimibe; oral

1.4

7.4

343

2531

K56.7

ICD-10 Finland

Ileus, unspecified

2.4

7.3

202

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

1.9

7.3

441

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

4.0

7.3

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.3

7.3

246

B01AB04

ATC

dalteparin; parenteral

1.7

7.3

142

872

I50.1

ICD-10 Finland

Left ventricular failure

1.8

7.3

113

652

TQW80

NOMESCO Finland

Local dermatologic skincare

2.0

7.3

393

2581B

ICD-9 Finland

Polyglandular dysfunction and related disorders, Other combinations of endocrine dysfunction[AUTOIMMUNE-POLYENDOCRINOPATHY-CANDIDOSIS-ECTOD DYST]

+∞

7.3

27340

ICD-8 Finland

Other and unspecified congenital disorders of metabolism, Other disorders involving metabolism of minerals

+∞

7.3

8010/3-C75.0

ICD-O-3

Carcinoma, NOS, of parathyroid gland

+∞

7.3

N16.2

ICD-10 Finland

Renal tubulo-interstitial disorders in blood diseases and disorders involving the immune mechanism

+∞

7.3

PG5ST

NOMESCO Finland

Endovascular thrombolysis of arterio-venous shunt for dialysis with radiological guidance

+∞

7.3

E85.3

ICD-10 Finland

Secondary systemic amyloidosis

+∞

7.3

I20.00

ICD-10 Finland

Unstable angina

2.1

7.3

292

C07AB05

ATC

betaxolol; oral

2.1

7.3

332

4019X

ICD-9 Finland

Essential hypertension, Unspecified

2.1

7.3

332

Z00.0

ICD-10 Finland

General medical examination

1.3

7.3

536

4241

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

3.5

7.3

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

3.2

7.2

M54.4

ICD-10 Finland

Lumbago with sciatica

1.3

7.2

474

3688

K73.80

ICD-10 Finland

Non-alcoholic fatty liver (NASH, Non Alcoholic Steatohepatitis)

6.2

7.2

L02

ICPC

Back symptom/complaint

1.5

7.2

252

1765

GD1LA

NOMESCO Finland

2.7

7.2

144

EE1AA

NOMESCO Finland

X-ray of upper jaw or palate

5.8

7.2

XX2RW, ,

NOMESCO Finland

2.9

7.2

116

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.5

7.2

249

1741

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

1.8

7.2

530

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

2.4

7.2

198

K29.2

ICD-10 Finland

Alcoholic gastritis

7.3

7.2

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

2.4

7.2

192

V03AA01, ,

ATC

2.5

7.2

174

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

2.2

7.2

281

NF1DA

NOMESCO Finland

X-ray of hips

2.1

7.1

321

D83.1

ICD-10 Finland

Common variable immunodeficiency with predominant immunoregulatory T-cell disorders

30.1

7.1

WE300

NOMESCO Finland

Profylactive therapy of malignancy with biomoidiers

30.1

7.1

M821, E2109,

ICD-10 Finland

30.1

7.1

4039A

ICD-9 Finland

Hypertensive renal disease, Unspecified

30.1

7.1

KAS40

NOMESCO Finland

Excision of transplanted kidney

30.1

7.1

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prosthodontic work

1.7

7.1

119

702

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

2.3

7.1

230

WX290

NOMESCO Finland

Other blockage of nerve

1.2

7.1

1285

11272

C73.99

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology

6.6

7.1

A06AC51

ATC

ispaghula, combinations; oral

1.7

7.1

129

779

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

2.4

7.1

187

D21

ICPC

Swallowing problem

2.5

7.1

175

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

12.0

7.1

M17.4

ICD-10 Finland

Other secondary gonarthrosis, bilateral

4.1

7.1

B37.8

ICD-10 Finland

Candidiasis of other sites

6.0

7.1

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

2.8

7.1

123

J01MA01

ATC

ofloxacin; systemic

1.5

7.1

223

1532

D07AB08

ATC

desonide; topical

1.4

7.0

287

2069

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.0

7.0

364

JMA10

NOMESCO Finland

Transabdominal total splenectomy

3.9

7.0

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

2.2

7.0

245

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.3

7.0

207

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

3.2

7.0

R00.2

ICD-10 Finland

Palpitations

1.5

7.0

198

1331

N28.9

ICD-10 Finland

Disorder of kidney and ureter, unspecified

4.4

7.0

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.4

7.0

279

2006

L13

ICPC

Hip symptom/complaint

1.3

6.9

518

4103

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

2.8

6.9

113

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.1

6.9

298

N03AE01

ATC

clonazepam; systemic

1.6

6.9

157

1003

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

6.9

415

JJA20

NOMESCO Finland

Open biopsy of liver

5.5

6.9

8260/3-C64.9

ICD-O-3

Papillary adenocarcinoma, NOS, of kidney, NOS

5.8

6.9

H04.10

ICD-10 Finland

Dry eye syndrome

1.4

6.9

304

2222

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.6

6.9

137

847

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

1.8

6.9

100

567

158

Kela drug reimbursment

Everolimus

13.8

6.9

A10BJ06

ATC

semaglutide; parenteral

1.7

6.9

113

664

K90.0

ICD-10 Finland

Coeliac disease

1.9

6.9

409

F34.1

ICD-10 Finland

Dysthymia

1.9

6.9

473

H36.00

ICD-10 Finland

Diabetic background retinopathy

2.7

6.9

125

WX419

NOMESCO Finland

Other general anesthesy

2.9

6.8

103

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

3.3

6.8

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.5

6.8

206

1403

JJC00

NOMESCO Finland

Allogenic transplantation of liver

6.7

6.8

A10AA02, ,

ATC

2.0

6.8

341

C25.4

ICD-10 Finland

Malignant neoplasm: Endocrine pancreas

10.9

6.8

PB1BC

NOMESCO Finland

Extensive angiography of upper extremity with X-ray

10.9

6.8

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

2.3

6.8

216

SPAT1151

SPAT

Treatment of major wounds

2.6

6.8

143

M14.6*E11.6

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic neuropathic

9.3

6.8

M14.6*A52.1

ICD-10 Finland

Charcot's or tabetic arthropathy

9.3

6.8

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.0

6.8

369

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.5

6.8

238

1670

RS220, ,

NOMESCO Finland

2.6

6.8

149

E000001, ,

ATC

1.3

6.8

537

4289

N03AF01

ATC

carbamazepine; oral, rectal

1.7

6.8

131

805

G63.8*N18.8

ICD-10 Finland

Uraemic neuropathy

40.1

6.8

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

4.3

6.7

EB1WA, ,

NOMESCO Finland

3.6

6.7

JA3FT

NOMESCO Finland

Exchange abdominal catheter with radiological guidance

16.7

6.7

L01XE26

ATC

[U] cabozantinib

16.7

6.7

E000003, ,

ATC

1.7

6.7

111

653

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

2.9

6.7

104

E05

ICD-10 Finland

Thyrotoxicosis [hyperthyroidism]

2.9

6.7

104

A07DA03

ATC

loperamide; oral

1.8

6.7

498

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.2

6.7

991

8507

EJA10

NOMESCO Finland

Biopsy of tongue or floor of mouth

2.1

6.7

282

K31.7

ICD-10 Finland

Polyp of stomach and duodenum

3.9

6.7

L14

ICPC

Leg/thigh symptom/complaint

1.5

6.7

213

1466

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.7

6.7

129

792

XQ800

NOMESCO Finland

Prick test

1.5

6.7

182

1213

N07BA03

ATC

varenicline; oral

1.7

6.7

116

693

JCA55

NOMESCO Finland

Endoscopic dilatation of oesophagus

3.0

6.6

A02BC04

ATC

rabeprazole; oral

1.5

6.6

234

1643

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

6.4

6.6

6BA02, ,

NOMESCO Finland

6.4

6.6

L01XE33

ATC

[U] palbociclib

4.0

6.6

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

1.7

6.6

118

710

B04AB02, ,

ATC

2.6

6.6

145

D12

ICPC

Constipation

1.8

6.6

523

C07AB08

ATC

celiprolol; oral

2.0

6.6

345

ZZA00

NOMESCO Finland

Split skin graft

1.9

6.6

408

M54

ICD-10 Finland

Dorsalgia

1.4

6.6

307

2266

A40.8

ICD-10 Finland

Other streptococcal sepsis

3.1

6.6

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

2.2

6.6

245

M87.9

ICD-10 Finland

Osteonecrosis, unspecified

3.5

6.6

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

3.3

6.5

Y88

ICD-10 Finland

Sequelae with surgical and medical care as external cause

3.3

6.5

TQW40

NOMESCO Finland

Remowal of suture of skin

1.5

6.5

194

1316

ZXD00

NOMESCO Finland

Emergency procedure

1.9

6.5

409

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.0

6.5

360

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

2.2

6.5

226

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

3.8

6.5

JJ3AT

NOMESCO Finland

Cytology of liver with ultrasound guidance

10.0

6.5

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

2.1

6.5

292

R23.3

ICD-10 Finland

Spontaneous ecchymoses

2.1

6.5

272

K02.9

ICD-10 Finland

Dental caries, unspecified

2.3

6.5

201

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

2.5

6.5

164

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

2.1

6.5

259

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.7

6.5

113

675

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

6.5

1062

9206

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.3

6.5

384

2943

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

1.8

6.5

475

D44.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Adrenal gland

2.7

6.5

129

D07AC01

ATC

betamethasone; topical

1.2

6.5

1040

9000

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

2.1

6.5

273

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.7

6.5

123

753

177

Kela drug reimbursment

Insulin glargine 300 U / ml

2.4

6.5

183

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

5.7

6.4

N083, E102,

ICD-10 Finland

70.0

6.4

25219

ICD-8 Finland

Diseases of parathyroid gland, Hypoparathyreoidismus alius sive NUD

70.0

6.4

J86.9

ICD-10 Finland

Pyothorax without fistula

2.9

6.4

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.9

6.4

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.2

6.4

241

XF612

NOMESCO Finland

Measurement of central venous pressure

7.4

6.4

2503B

ICD-9 Finland

Diabetes mellitus, Diabetes with other coma[SOKERITAUDIN AIHEUTTAMA MUNUAISSAIRAUS,TYYPPI I]

14.3

6.4

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

1.9

6.4

434

A10BX02

ATC

repaglinide; oral

2.6

6.4

136

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.6

6.4

128

795

N03AX18

ATC

lacosamide; systemic

3.7

6.4

EB1BA

NOMESCO Finland

Extensive intraoral X-ray examination

3.7

6.4

D34

ICD-10 Finland

Benign neoplasm of thyroid gland

3.0

6.3

K05.31

ICD-10 Finland

Periodontitis pronounced

1.4

6.3

292

2152

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.4

6.3

305

2265

WVA30, ,

SPAT

1.6

6.3

139

883

K85

ICD-10 Finland

Acute pancreatitis

2.3

6.3

204

ZYY98

NOMESCO Finland

Missed treatment contact, no notification given by patient

5.9

6.3

N03.9

ICD-10 Finland

Chronic nephritic syndrome, unspecified

5.5

6.3

2505

FHL

Bilateral resection (also used if total removal has been performed on the other side)

3.3

6.3

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

1.8

6.3

517

M80

ICD-10 Finland

Osteoporosis with pathological fracture

2.9

6.3

C80.91

ICD-10 Finland

Malignant tumor without specified localization epidermoid carcinoma

18.0

6.3

D77

ICPC

Malignant digestive neopl other/NOS

3.8

6.3

N05AH03

ATC

olanzapine; systemic

1.6

6.3

153

996

26510

ICD-8 Finland

Vitamin D deficiency, Rickets, late effect

+∞

6.3

E83

ICD-10 Finland

Disorders of mineral metabolism

+∞

6.3

2759X

ICD-9 Finland

Disorders of mineral metabolism, Unspecified disorder of mineral metabolism

+∞

6.3

E67.3

ICD-10 Finland

Hypervitaminosis D

+∞

6.3

PBM09

NOMESCO Finland

Closure of arteriovenous fistula of brachial artery

+∞

6.3

M821, E8358,

ICD-10 Finland

+∞

6.3

L01XE17

ATC

[U] axitinib

+∞

6.3

Z71.9

ICD-10 Finland

Counselling, unspecified

1.5

6.2

171

1141

U04

ICPC

Incontinence urine

1.6

6.2

139

885

PC6DE, ,

NOMESCO Finland

26.7

6.2

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.2

6.2

218

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.5

6.2

176

1183

J45.8

ICD-10 Finland

Mixed asthma

1.8

6.2

438

A01AB04

ATC

amphotericin B; local oral

1.6

6.2

120

738

IGY02, ,

SPAT

2.9

6.2

A10BK03

ATC

empagliflozin; oral

1.4

6.2

231

1640

H06.2*E05.9

ICD-10 Finland

Dysthyroid exophthalmos

3.7

6.2

E53.8

ICD-10 Finland

Deficiency of other specified B group vitamins

3.7

6.2

PJA10

NOMESCO Finland

Exploration of lymph nodes

2.4

6.2

162

D51.9

ICD-10 Finland

Vitamin B12deficiency anaemia, unspecified

2.7

6.2

115

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.3

6.2

375

2886

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

1.8

6.2

432

B82

ICPC

Anaemia other/unspecified

1.9

6.2

354

Z2221

NOMESCO Finland

Medical doctor

1.2

6.2

727

6087

K31.8

ICD-10 Finland

Other specified diseases of stomach and duodenum

3.5

6.2

Angiography of the heart and coronary arteries

1.6

6.1

125

779

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.7

6.1

108

648

UJF02

NOMESCO Finland

Peroral enteroscopy

3.4

6.1

H35.8

ICD-10 Finland

Other specified retinal disorders

3.4

6.1

N39.9

ICD-10 Finland

Disorder of urinary system, unspecified

2.3

6.1

194

M43.1

ICD-10 Finland

Spondylolisthesis

1.7

6.1

107

641

QDH05

NOMESCO Finland

Correction of deformity of toe nail

7.7

6.1

C08CA03

ATC

isradipine; systemic

2.6

6.1

133

N02AA01

ATC

morphine; systemic, rectal

2.2

6.1

207

D45

ICD-10 Finland

Polycythaemia vera

2.8

6.1

162

Kela drug reimbursment

liraglutide

2.8

6.1

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

1.9

6.1

405

J20

ICD-10 Finland

Acute bronchitis

1.4

6.1

257

1866

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

4.1

6.1

Q61.2

ICD-10 Finland

Polycystic kidney, autosomal dominant

3.8

6.1

S01.50

ICD-10 Finland

Open wound in oral cavity

2.7

6.1

116

L02BG06

ATC

exemestane; oral

2.1

6.1

240

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.4

6.1

336

2550

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.4

6.1

315

2367

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

1.8

6.1

449

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

2.3

6.0

195

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

2.3

6.0

195

D86.3

ICD-10 Finland

Sarcoidosis of skin

8.6

6.0

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.5

6.0

154

1012

NH1AD

NOMESCO Finland

Ankle and foot CT

2.0

6.0

294

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

1.9

6.0

406

A10BX04

ATC

[U] exenatide

2.9

6.0

N08.2

ICD-10 Finland

Glomerular disorders in blood diseases and disorders involving the immune mechanism

6.7

6.0

E13.7

ICD-10 Finland

Other specified diabetes mellitus, with multiple complications

10.0

6.0

8160/3-C24.9

ICD-O-3

Cholangiocarcinoma of billiary tract, NOS

10.0

6.0

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.4

6.0

240

1725

JF1AD

NOMESCO Finland

Small bowel CT

3.2

6.0

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

3.2

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3036481) Cortisol [Moles/volume] in Serum or Plasma

856

2195

4.81

313.69

2.5

2.3

373.56

364.54

nmol/l

0.58

804

2015

(3022948) Iron [Moles/volume] in Serum or Plasma

1430

3974

5.33

307.65

5.5

2.2

15.18

13.35

umol/l

10.93

1350

3711

(3010838) Calcium [Moles/time] in 24 hour Urine

861

406

27.60

307.65

2.7

1.8

5.45

4.89

mmol/24h

2.22

774

353

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1344

3404

5.72

307.65

5.6

2.3

29.42

23.08

23.66

1180

2918

(3034860) Kappa light chains.free [Mass/volume] in Serum

516

750

7.87

307.65

4.3

3.6

60.67

60.28

mg/l

0.01

399

603

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2480

11500

4.76

307.65

4.3

2.1

75.74

78.61

nmol/l

4.49

2333

10224

(3024561) Albumin [Mass/volume] in Serum or Plasma

2406

11859

4.14

307.65

9.5

4.5

34.17

35.64

g/l

26.61

2290

10968

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

448

438

11.55

307.65

4.2

2.7

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

506

725

7.96

307.65

4.2

3.4

3.29

1.95

ratio

0.31

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1626

1817

15.56

307.65

6.1

3.4

87.29

85.81

ng/l

0.16

1403

1547

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

512

748

7.82

307.65

4.3

3.5

74.46

51.39

mg/l

0.38

395

605

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1714

4120

7.06

307.65

7.3

3.3

0.77

0.82

mmol/l

39.87

1634

3849

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2655

12609

5.28

307.65

18.5

5.1

1.23

1.21

mmol/l

13.54

2538

11389

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2898

13886

6.70

307.65

22.5

5.7

1.24

1.22

mmol/l

14.56

2462

11717

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1842

3145

11.00

307.65

10.6

5.3

1.03

mmol/l

0.18

1756

2919

(3018418) pH of Serum or Plasma

1994

8058

4.33

307.65

14.7

3.5

7.40

0.16

532

1564

(3020779) Urea [Moles/volume] in Serum or Plasma

901

2142

5.28

307.65

14.2

6.6

11.92

9.24

mmol/l

20.48

868

2046

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1382

3652

5.53

307.65

5.5

2.2

2.18

2.34

g/l

18.74

1305

3372

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

179

47.05

305.11

1.2

1.1

3.00

10.04

pmol/l

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

2028

9602

3.56

303.43

5.7

3.4

2.38

2.36

mmol/l

2.26

1840

8388

(3004588) Protein electrophoresis panel - Serum or Plasma

757

1805

5.05

302.38

3.4

2.3

—

(40760888) Immunoglobulin light chains.free panel - Serum

409

565

8.04

284.82

4.1

3.6

—

(3020630) Protein [Mass/volume] in Serum or Plasma

811

2158

4.57

281.36

3.7

2.5

65.32

66.73

g/l

4.64

736

1968

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

559

1087

5.91

280.14

2.9

1.9

41.13

39.54

u/l

0.77

491

965

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

260

198

14.08

277.15

1.4

1.2

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

953

2953

4.03

268.15

4.5

4.4

251.30

245.10

u/l

0.51

901

2810

(3012544) pH of Venous blood

809

2325

4.20

251.34

8.7

3.5

7.37

7.36

0.12

(3021447) Carbon dioxide [Partial pressure] in Venous blood

796

2268

4.23

250.13

8.9

3.5

5.86

5.84

kpa

0.16

776

2201

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2510

14580

3.41

249.75

10.5

6.0

11.08

11.50

umol/l

0.76

2423

13799

(3002032) Base excess in Venous blood by calculation

787

2256

4.19

244.88

9.0

3.5

2.29

2.01

mmol/l

0.94

688

1903

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2148

11549

3.15

241.06

6.2

2.6

245.44

129.10

ug/l

17.86

2021

10617

(40760892) CBC W Ordered Manual Differential panel - Blood

2331

13146

3.21

240.11

9.4

6.3

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

409

684

6.62

237.90

2.8

1.9

13.34

11.46

mg/l

2.10

366

635

(3013115) Eosinophils [#/volume] in Blood

2439

14470

3.15

222.78

8.3

5.9

0.19

e9/l

0.31

2216

12697

(3006315) Basophils [#/volume] in Blood

2387

13996

3.12

222.60

8.1

5.7

0.04

e9/l

0.16

2152

12102

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1484

6728

3.06

221.14

3.0

2.1

3.09

2.98

mg/l

0.75

1305

5755

(3001604) Monocytes [#/volume] in Blood

2379

13956

3.10

220.99

8.1

5.7

0.62

0.58

e9/l

4.56

2149

12077

(3022217) INR in Platelet poor plasma by Coagulation assay

2229

12756

2.98

213.94

15.6

13.9

1.19

1.27

inr

4.92

763

3740

(3022096) Basophils/100 leukocytes in Blood

2210

12614

2.96

212.70

8.5

6.0

0.66

0.68

1.15

2094

11724

(3023368) Bacteria identified in Blood by Culture

1544

7279

2.97

212.54

7.1

3.9

—

(3019069) Monocytes/100 leukocytes in Blood

2266

13123

2.98

211.98

8.8

6.2

8.73

8.63

0.81

2154

12245

(3019198) Lymphocytes [#/volume] in Blood

2403

14372

3.04

211.66

8.3

5.8

1.80

1.93

e9/l

3.42

2201

12724

(3006504) Eosinophils/100 leukocytes in Blood

2253

13033

2.96

210.72

8.5

5.9

2.70

2.88

3.41

2142

12137

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3155

22227

4.53

210.43

14.9

7.1

88.22

77.97

u/l

16.44

3078

20816

(3002030) Lymphocytes/100 leukocytes in Blood

2290

13476

2.94

205.30

8.7

6.0

25.67

28.14

20.10

2174

12596

(3013650) Neutrophils [#/volume] in Blood by Automated count

2583

16366

3.07

199.13

14.6

8.8

4.30

4.04

e9/l

6.23

2364

14276

(3027945) Reticulocytes/100 erythrocytes in Blood

838

2920

3.44

191.61

3.7

2.6

1.97

1.74

6.76

756

2597

(3005719) IgG [Mass/volume] in Serum or Plasma

661

1974

3.88

190.93

3.6

2.8

10.44

10.57

g/l

0.22

604

1801

(3018010) Neutrophils/100 leukocytes in Blood

2233

13288

2.81

190.10

8.2

5.8

58.91

56.94

11.11

2127

12407

(3023520) Reticulocytes [#/volume] in Blood

697

2191

3.71

186.45

3.7

2.7

71.48

68.12

e9/l

1.26

544

1640

(3000991) Gas panel - Venous blood

678

2096

3.76

185.88

11.8

7.2

—

(3009343) pH of Capillary blood

576

1600

4.10

183.87

6.0

3.5

7.42

7.41

0.25

103

178

(3028026) IgM [Mass/volume] in Serum or Plasma

556

1518

4.15

181.63

2.4

2.0

1.11

1.46

g/l

3.59

498

1380

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

578

1628

4.04

180.84

6.1

3.5

5.10

5.18

kpa

1.17

557

1554

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

559

1555

4.07

177.79

6.0

3.5

2.07

1.81

mmol/l

0.76

425

1171

(3037756) Immunofixation for Serum or Plasma

309

529

6.30

174.45

2.2

1.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

747

2577

3.40

171.98

3.2

2.3

0.21

g/l

0.63

697

2420

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

593

1798

3.75

166.18

2.3

1.6

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

531

1499

3.98

164.86

4.1

3.0

4.41

4.46

pmol/l

0.35

475

1326

(3013826) Glucose [Moles/volume] in Serum or Plasma

2501

16418

2.74

164.36

9.0

4.1

6.78

6.64

mmol/l

2.88

2420

15307

(3024354) Oxygen [Partial pressure] in Venous blood

614

1919

3.65

164.35

7.0

3.0

4.78

4.62

kpa

0.80

591

1861

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

101

38.46

164.16

1.0

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

439

1079

4.50

164.10

2.0

1.8

1.59

1.51

g/l

0.84

379

934

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1638

8804

2.59

163.71

3.6

2.4

58.55

59.89

u/l

0.37

1553

8078

(3026493) Urate [Moles/volume] in Serum or Plasma

1432

7219

2.64

163.47

4.5

2.5

2194.40

4593.30

umol/l

2.27

1288

6289

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

683

2306

3.42

162.04

12.9

3.2

1.24

1.23

mmol/l

0.97

641

1977

(3012565) Volume of 24 hour Urine

145

108

13.95

155.83

2.9

2.3

2162.03

1864.03

1.37

138

(1616796) Gas panel - Central venous blood

288

514

6.01

155.52

5.1

3.7

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

445

1169

4.20

152.03

8.4

4.0

24.17

24.20

mmol/l

0.07

438

1147

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

324

678

5.15

146.85

5.1

4.2

1.88

1.43

mg/l

10.70

300

624

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

392

990

4.32

140.77

3.5

2.3

7.50

7.32

g/l

1.11

346

894

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

391

989

4.32

140.11

3.5

2.3

—

(3026782) Osmolality of Urine

1121

5344

2.60

139.51

4.1

2.6

506.14

552.06

mosm/kgh2o

10.23

1013

4541

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

390

989

4.30

139.26

3.5

2.3

3.80

3.64

g/l

1.00

345

896

(3015235) Bicarbonate [Moles/volume] in Capillary blood

290

577

5.38

139.04

4.7

2.8

24.42

24.99

mmol/l

1.10

284

566

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

946

4229

2.68

133.40

2.4

1.7

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

368

931

4.29

131.60

3.6

2.3

9.66

10.32

g/l

1.71

321

827

(3007164) IgA [Mass/volume] in Serum or Plasma

1081

5205

2.54

130.36

2.1

1.4

2.72

2.43

g/l

1.41

749

3123

(3002582) Erythrocytes [#/volume] in Urine

1483

8257

2.36

129.23

4.9

2.9

57.35

96.74

e6/l

1.39

1228

6267

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1078

5204

2.53

129.10

4.8

3.1

2.52

2.45

mmol/l

11.43

954

4593

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

306

679

4.83

129.08

1.6

1.3

—

(3020876) Protein [Mass/time] in 24 hour Urine

182

244

7.80

128.58

3.2

2.2

0.93

1.35

g/24h

0.69

121

117

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1547

8803

2.33

127.76

4.6

3.1

39.64

34.28

u/l

0.54

1471

8307

(3023183) Ammonium ion [Moles/volume] in Plasma

252

477

5.61

127.47

4.0

2.9

34.80

36.06

umol/l

0.30

226

437

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

255

488

5.55

127.46

7.3

4.9

856.17

3847.18

iu/ml

0.42

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

363

931

4.23

127.36

3.6

2.3

2.94

2.96

g/l

0.11

317

838

(3017181) Myelocytes/100 leukocytes in Blood

633

2340

3.07

126.91

4.9

4.1

0.91

0.97

0.28

321

757

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1440

7966

2.35

126.81

2.6

2.0

228.72

216.70

u/l

0.15

1372

7450

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

126

107

12.17

124.92

6.9

6.1

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

375

1002

4.06

124.38

2.7

1.9

2.45

2.56

ug/l

0.04

342

891

(3013707) Erythrocyte sedimentation rate by Westergren method

2855

21356

2.66

121.74

6.0

4.0

17.17

11.93

mm/h

36.70

2690

19671

(21494890) Protein electrophoresis panel - 24 hour Urine

177

245

7.55

121.56

2.9

2.0

—

(3021901) Oxygen saturation in Capillary blood

228

412

5.84

121.11

3.8

2.4

—

(3003181) Sodium [Moles/volume] in Urine

175

241

7.58

120.72

2.2

1.3

60.93

70.24

mmol/l

1.54

150

186

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

484

1575

3.40

119.69

8.8

7.0

24.73

24.93

mmol/l

0.46

477

1566

(3021440) Promyelocytes/100 leukocytes in Blood

600

2230

3.03

118.62

5.0

4.1

0.16

0.11

0.84

290

651

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

334

850

4.23

118.18

3.7

2.4

0.80

1.19

g/l

0.86

267

742

(3028626) Oxygen [Partial pressure] in Capillary blood

270

581

4.94

117.96

4.7

3.4

8.24

8.44

kpa

0.99

265

570

(3026008) Bacteria identified in Urine by Culture

1469

8388

2.27

117.95

4.0

3.0

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

459

1461

3.46

117.46

7.2

2.9

120.17

129.67

g/l

14.86

448

1423

(3019309) Folate [Moles/volume] in Red Blood Cells

1038

5121

2.45

116.80

2.0

1.7

1316.95

1167.73

nmol/l

3.73

814

3857

(3014111) Lactate [Moles/volume] in Serum or Plasma

592

2218

3.00

115.16

9.4

6.1

1.44

1.35

mmol/l

0.80

577

2166

(3018095) Leukocytes [#/volume] in Urine

1615

9675

2.22

114.30

5.7

3.3

133.65

102.86

e6/l

0.79

1282

6806

(3027273) Bicarbonate [Moles/volume] in Venous blood

394

1161

3.69

113.29

8.6

2.9

25.45

mmol/l

0.00

382

1125

(3018677) aPTT in Platelet poor plasma by Coagulation assay

853

3903

2.56

112.36

2.5

2.0

29.77

29.70

0.12

829

3778

(3002179) Metamyelocytes/100 leukocytes in Blood

576

2153

3.00

112.34

4.8

4.0

0.83

0.68

0.49

286

657

(3000850) Epithelial cells [#/volume] in Urine

1118

5800

2.35

111.43

3.9

2.3

5.13

5.57

e6/l

0.59

1041

5139

(3030467) Casts [#/volume] in Urine by Automated count

1358

7667

2.24

110.37

4.5

2.9

0.55

0.40

e6/l

1.32

1115

5801

(3025159) Blasts/100 leukocytes in Blood

566

2124

2.98

109.44

4.8

4.1

0.04

0.56

1.42

252

550

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1345

7616

2.23

108.01

3.5

2.8

2617.63

1221.30

ng/l

6.08

1167

6466

(3037467) Urinalysis macro (dipstick) panel - Urine

2657

19678

2.36

107.93

6.6

4.0

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1785

11350

2.14

106.05

2.5

1.9

94.80

95.99

pmol/l

0.44

993

5830

(3044640) Blood type and Crossmatch panel - Blood

1489

8842

2.17

105.47

3.6

2.3

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1676

10440

2.14

104.64

5.2

3.1

40.68

95.42

ng/l

0.65

1337

7082

(3021960) Folate [Moles/volume] in Serum or Plasma

1170

6329

2.26

104.40

1.9

1.5

20.27

20.93

nmol/l

0.51

1005

5337

(3037121) Protein [Mass/volume] in Urine

334

932

3.85

103.73

3.9

3.0

0.44

0.26

g/l

2.39

176

364

(3022313) Gas panel - Capillary blood

388

1204

3.49

102.80

6.2

3.8

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1973

13220

2.10

99.86

3.6

2.5

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

145

201

7.48

99.33

6.0

4.0

81.30

110.18

u/ml

0.18

(3016502) Oxygen saturation in Arterial blood

624

2593

2.70

98.89

8.7

6.9

95.00

95.75

1.60

603

2503

(36304419) Bacteria [Presence] in Urine

1300

7477

2.16

98.33

4.3

2.8

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

295

784

4.01

98.01

3.5

2.2

36.32

37.81

g/l

2.87

248

688

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

285

739

4.10

97.94

3.6

2.3

0.03

g/l

0.15

248

687

(40767503) Oxygen content in Capillary blood by calculation

237

535

4.67

97.45

3.8

2.1

15.57

16.47

1.84

141

242

(3003396) Base excess in Arterial blood by calculation

672

2934

2.59

96.16

8.4

6.5

1.18

1.11

mmol/l

0.14

554

2309

(3031040) Bacteria [#/volume] in Urine by Automated count

2528

18743

2.19

96.09

6.4

4.2

1198.31

1897.89

e6/l

0.36

219

(3009508) Creatinine [Moles/volume] in Urine

1413

8481

2.10

94.76

4.3

3.0

6.76

7.65

mmol/l

12.14

1226

7126

(3033658) Prothrombin time (PT) actual/Normal

1214

6888

2.15

94.29

6.6

3.7

90.27

90.13

0.07

1182

6708

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

649

2822

2.59

93.44

2.1

1.6

—

(3042936) Bacteria identified in Isolate by Culture

796

3816

2.40

92.74

2.7

1.9

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

649

2836

2.57

92.40

2.1

1.5

—

(3010421) pH of Blood

267

689

4.11

92.26

6.3

3.9

7.43

7.42

0.46

242

624

(3037522) Nuclear Ab [Titer] in Serum

769

3650

2.41

91.50

1.5

1.3

483.46

532.35

titre

0.33

162

774

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

193

387

5.21

91.23

4.0

3.0

485.86

1778.35

u/ml

0.90

(3027801) Oxygen [Partial pressure] in Arterial blood

664

2958

2.53

90.65

8.5

6.5

11.62

12.56

kpa

4.87

642

2815

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

664

2958

2.53

90.65

8.5

6.5

5.05

5.13

kpa

1.18

641

2819

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

265

691

4.06

90.24

3.6

2.3

0.00

g/l

0.50

228

642

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2804

21933

2.28

89.25

6.4

3.8

15.34

14.79

pmol/l

19.94

2615

19747

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

641

2830

2.54

89.06

2.1

1.7

—

(3012501) Base excess in Blood by calculation

237

578

4.32

88.23

5.8

4.0

2.92

2.70

mmol/l

0.53

187

391

(3013290) Carbon dioxide [Partial pressure] in Blood

237

579

4.31

88.03

5.8

4.0

5.03

kpa

0.02

230

569

(3004809) Band form neutrophils/100 leukocytes in Blood

202

436

4.85

87.60

3.5

1.62

1.53

0.11

183

387

(3027315) Oxygen [Partial pressure] in Blood

238

586

4.28

87.49

5.8

4.1

8.75

8.49

kpa

1.27

231

576

(3009445) Proteinase 3 Ab [Units/volume] in Serum

345

1098

3.37

87.41

1.3

1.5

2.94

20.70

u/ml

—

(3017704) Immunofixation for Urine

105

117

9.22

86.02

1.8

1.6

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

258

685

3.98

85.62

3.7

2.3

0.00

g/l

-0.00

228

641

(3002173) Hemoglobin [Mass/volume] in Arterial blood

565

2396

2.61

85.07

9.3

7.2

115.40

121.79

g/l

9.26

554

2329

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2463

18489

2.06

84.74

5.0

2.9

71.28

46.76

u/l

16.19

2332

17084

(3000012) Reticulocyte production index

175

347

5.25

83.72

2.1

2.2

—

(3007853) Bacteria identified in Skin by Aerobe culture

677

3147

2.42

83.69

2.1

1.6

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

339

1112

3.26

81.62

8.0

3.3

49.90

49.51

0.09

332

1096

(3026250) Tacrolimus [Mass/volume] in Blood

10.35

81.34

42.5

32.1

7.03

7.39

ug/l

0.46

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

235

605

4.09

81.31

1.9

1.6

—

(3021589) Normoblasts [#/volume] in Blood

1852

12705

1.95

81.24

19.2

8.9

0.00

e9/l

0.09

1585

10419

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

340

1127

3.23

80.43

6.2

2.6

0.66

0.65

0.08

340

1121

(3020682) Albumin/Creatinine [Ratio] in Urine

1346

8362

1.98

78.35

5.2

3.5

33.62

6.86

mg/mmol

1.61

950

5109

(3012516) Albumin [Mass/volume] in Urine

1297

7957

1.99

78.28

4.4

3.0

1114.86

342.49

mg/l

3.55

945

4924

(4035726) Immunohistochemistry procedure

582

2599

2.48

78.15

1.6

1.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

181

396

4.76

77.14

1.4

1.2

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

11.68

76.77

1.7

1.5

0.44

0.43

ug/l

0.04

(3011985) Renin [Units/volume] in Plasma

150

282

5.51

76.09

2.2

1.4

68.49

44.31

mu/l

0.46

133

248

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

710

3509

2.28

75.47

2.1

1.6

—

(40768446) Kidney Pathology biopsy report

10.47

74.86

1.8

1.4

—

(3035350) Ketones [Presence] in Urine by Test strip

1949

13836

1.90

74.60

5.1

3.5

0.00

estimate

0.30

563

2789

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

273

828

3.49

74.34

3.7

3.1

0.31

0.34

u/ml

0.65

149

462

(3035637) Corticotropin [Mass/volume] in Plasma

149

289

5.34

73.01

1.6

1.5

—

(3024928) Oxygen saturation in Venous blood

193

468

4.30

72.24

5.2

3.2

—

(3019225) pH of Specimen

628

2999

2.33

72.10

14.5

3.6

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

138

258

5.52

70.40

1.3

1.2

71.71

60.90

u/l

0.68

127

228

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1132

6827

1.96

70.20

3.5

2.3

—

(3021601) Nitrite [Presence] in Urine by Test strip

1929

13827

1.86

69.76

6.8

4.6

0.00

estimate

0.24

538

2621

(3009261) Glucose [Presence] in Urine by Test strip

1945

14008

1.85

68.96

5.2

3.5

0.01

0.00

estimate

0.09

526

2552

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

385

1492

2.77

68.57

1.8

1.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

236

687

3.61

68.33

1.3

1.2

96.96

101.84

titre

0.06

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

609

2946

2.29

67.48

5.3

3.0

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

313

1094

3.04

67.33

7.0

3.8

24.95

24.93

mmol/l

0.04

299

1022

(3044927) Protein electrophoresis panel - Urine

137

265

5.34

67.31

1.3

1.1

—

(3047189) Immunofixation for 24 hour Urine

116

8.02

66.90

2.9

1.7

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

228

659

3.63

66.70

2.0

1.5

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1021

6050

1.96

65.94

1.4

1.3

1.14

1.80

u/ml

1.45

268

1582

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

196

516

3.96

65.61

1.9

1.4

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

613

3006

2.25

65.59

4.8

2.8

9.00

8.08

umol/l

0.40

529

2612

(3016038) Potassium [Moles/volume] in Urine

9.26

65.24

2.5

1.4

35.93

35.82

mmol/l

0.01

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

209

580

3.76

64.90

2.0

1.7

5.04

4.54

iu/l

0.26

187

(3006184) Hemoglobin [Mass/volume] in Capillary blood

197

531

3.87

63.78

3.3

2.0

122.86

130.36

g/l

3.01

167

371

(3034770) Mitochondria Ab [Titer] in Serum

229

684

3.51

63.70

1.3

1.2

902.86

1070.00

titre

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

179

454

4.10

63.04

1.6

1.7

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

768

4172

2.07

62.98

2.2

1.8

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1002

5982

1.94

62.78

1.9

1.7

1.43

1.20

mg/l

1.52

771

4514

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

15.21

61.42

1.8

1.4

110.52

120.97

ng/l

0.12

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

256

839

3.21

61.35

2.4

2.2

466.96

629.38

ug/l

0.26

239

788

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

765

4195

2.05

60.92

4.0

2.7

3.25

2.59

e6/l

0.96

443

2262

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

188

507

3.86

60.80

1.5

1.2

—

(3013512) EKG study

1294

8457

1.83

60.65

4.9

3.5

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

191

524

3.79

60.27

1.9

1.3

12.27

12.06

u/ml

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

115

210

5.62

60.15

2.4

1.9

6.42

3.72

mg/l

4.80

106

200

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

259

866

3.15

59.99

1.7

1.6

292.50

249.33

titre

0.08

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

593

2973

2.19

59.64

3.7

4.1

35.58

24.03

ug/l

0.50

503

2408

(3017817) Protein [Mass] in Urine collected for unspecified duration

113

206

5.63

59.21

2.4

2.3

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

149

345

4.46

59.11

7.4

6.5

13.10

11.48

mg/l

3.62

131

321

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

216

652

3.46

59.06

2.0

1.6

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

182

492

3.84

58.64

2.0

1.6

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

178

474

3.90

58.59

1.6

1.2

285.86

282.59

u/ml

0.05

110

287

(3002079) Sodium [Moles/time] in 24 hour Urine

8.85

58.28

1.6

1.3

158.49

152.27

mmol/24h

0.22

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

129

269

4.94

58.15

1.3

1242.02

296.20

pmol/l

0.63

109

233

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

176

469

3.89

57.87

1.9

1.4

111.81

120.48

u/ml

0.38

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

991

6048

1.88

57.17

1.9

1.6

475.29

32935519.29

pmol/l

4.62

819

5022

(3008152) Bicarbonate [Moles/volume] in Arterial blood

382

1613

2.53

56.87

8.1

6.8

24.62

24.67

mmol/l

0.07

367

1534

(3000570) Elastase.pancreatic [Mass/mass] in Stool

244

813

3.15

56.81

1.4

244.52

284.12

ug/g

2.03

153

467

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

806

4623

1.96

55.93

3.6

2.6

1.27

1.12

e6/l

0.43

480

2670

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3286

29045

2.59

55.68

32.2

12.6

24.01

23.89

mg/l

0.08

2935

22603

(3019060) Gas panel - Arterial blood

398

1730

2.46

55.64

5.7

4.6

—

(40768797) Stomach Pathology biopsy report

706

3878

2.02

55.39

1.3

1.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

332

1330

2.65

55.02

11.2

9.0

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3074

26489

2.13

54.36

7.6

4.5

1.93

2.05

mu/l

0.77

2883

24024

(3021879) Hepatitis B virus core Ab [Presence] in Serum

410

1834

2.40

53.73

1.6

1.4

—

(3025549) Creatine [Moles/time] in 24 hour Urine

17.12

53.15

1.4

1.3

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

149

376

4.09

52.80

1.7

1.5

—

(3015736) pH of Urine

1553

11020

1.72

52.76

4.4

3.3

5.88

5.82

0.21

795

(3048929) Epstein Barr virus Ab [Presence] in Serum

224

757

3.09

50.83

1.5

1.2

—

(3042733) HLA Ab [Presence] in Serum

8.87

49.67

5.6

4.8

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

167

5.69

49.51

1.7

1.5

6.12

6.24

u/l

0.03

140

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

135

332

4.19

49.51

1.2

1.3

0.67

0.63

nmol/l

0.35

129

319

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

266

1004

2.78

49.40

7.0

5.0

1.67

1.62

0.33

252

935

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

136

338

4.14

49.18

1.2

1.3

0.23

0.40

nmol/l

0.62

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

185

5.36

48.39

1.2

1.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

186

580

3.33

48.23

1.7

1.3

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

126

300

4.32

48.22

1.7

1.5

—

(3029937) Albumin [Presence] in Urine by Test strip

1156

7708

1.74

48.04

5.6

3.8

0.00

estimate

1.60

498

2551

(3017354) Segmented neutrophils/100 leukocytes in Blood

122

285

4.40

47.84

3.2

3.7

62.76

55.10

2.86

104

239

(3007930) Methemoglobin/Hemoglobin.total in Blood

261

992

2.76

47.81

7.0

5.0

0.89

0.90

0.08

249

920

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

103

210

5.02

47.66

1.7

1.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

218

757

3.00

47.15

2.5

1.6

—

(3022806) Fractional oxyhemoglobin in Capillary blood

136

352

3.98

46.54

2.6

1.5

89.96

89.93

0.02

131

346

(40758558) Short blood count panel - Blood

1085

7159

1.74

46.51

10.7

6.5

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

316

1341

2.49

46.25

10.2

8.1

24.03

24.37

mmol/l

0.83

306

1300

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

7.16

46.18

3.0

2.8

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

112

252

4.56

46.05

1.3

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1110

7392

1.73

45.91

5.0

3.1

—

(40768441) Liver Pathology biopsy report

191

5.14

45.68

1.6

1.4

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

221

791

2.91

45.26

1.6

1.18

1.17

g/l

0.18

208

760

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1494

10799

1.66

45.17

5.4

3.6

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

215

761

2.94

44.92

1.6

0.25

0.23

g/l

1.26

201

731

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

114

266

4.39

44.77

2.5

2.4

—

(40761536) Microorganisms panel - Urine sediment

483

2483

2.09

44.66

5.5

3.6

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

238

900

2.76

43.97

2.8

2.7

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

122

304

4.12

43.97

1.2

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

147

5.69

43.74

1.6

1.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

332

1482

2.37

43.38

2.0

1.6

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

206

4.76

41.83

1.3

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

13.59

41.66

17.2

8.4

4.69

6.37

mmol/l

1.79

(3019550) Sodium [Moles/volume] in Serum or Plasma

3333

30304

2.44

41.55

37.7

14.0

139.29

139.79

mmol/l

23.90

3297

29467

(3008295) Osmolality of Serum or Plasma

192

4.89

41.44

1.5

277.38

285.59

mosm/kgh2o

2.00

144

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

144

5.59

41.41

1.6

1.4

—

(3018405) Lactate [Moles/volume] in Arterial blood

242

958

2.64

40.82

4.3

3.8

1.50

1.34

mmol/l

0.97

234

951

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

207

760

2.83

40.40

2.7

3.55

3.48

g/l

0.23

195

723

(3023103) Potassium [Moles/volume] in Serum or Plasma

3336

30400

2.42

40.37

38.4

14.1

3.97

mmol/l

0.11

3295

29502

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

135

384

3.61

40.34

1.6

1.4

—

(3025941) Bacteria identified in Stool by Culture

324

1479

2.31

40.12

1.5

1.2

—

(3045142) Bone marrow Pathology biopsy report

116

306

3.88

38.67

1.5

1.3

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

167

561

3.07

38.22

4.6

3.5

60.78

57.40

2.51

167

561

(3000494) Fungus identified in Specimen by Culture

570

3268

1.89

38.12

1.8

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

152

485

3.23

37.94

1.6

1.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

195

718

2.81

37.84

1.3

—

(3011412) CD3 cells [#/volume] in Blood

103

254

4.15

37.65

2.3

2.4

1.09

1.14

e9/l

0.19

226

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

139

425

3.36

37.17

1.6

1.4

—

(3047181) Lactate [Moles/volume] in Blood

201

761

2.74

36.99

7.8

5.9

1.46

1.22

mmol/l

1.86

181

663

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

123

349

3.61

36.90

1.1

1.59

1.49

g/l

1.35

114

308

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

112

299

3.83

36.71

1.3

—

nmol/l

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

146

5.23

36.60

1.4

1.1

96.75

92.90

u/l

0.09

122

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

139

5.34

36.51

1.4

1.1

32.84

23.31

u/l

0.58

113

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

132

5.47

36.45

1.2

1.1

112.45

92.10

u/l

0.49

121

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

251

1067

2.45

36.43

2.3

1.7

—

(3040151) Glucose [Moles/volume] in Capillary blood

100

253

4.04

35.33

8.6

4.1

7.18

6.91

mmol/l

0.38

211

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

120

345

3.56

35.30

1.7

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

122

356

3.51

35.09

1.7

1.3

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

137

432

3.26

34.87

1.3

26.00

39.18

u/l

1.09

123

371

(3008757) Leukocyte morphology finding [Identifier] in Blood

110

301

3.74

34.81

3.9

4.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

263

1170

2.35

34.46

2.7

1.8

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

125

375

3.42

34.45

1.7

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

174

4.68

34.32

1.8

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

120

352

3.49

34.24

1.7

1.3

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

10.37

34.23

2.9

2.3

77.22

25.34

mg/l

—

(3020891) Body temperature

254

1118

2.37

34.09

7.9

4.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

236

4.06

33.56

3.4

2.7

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

162

4.77

33.41

1.2

1.1

—

(40768804) Tissue Pathology biopsy report

1550

11911

1.53

32.65

2.3

2.1

—

(3042631) Mycobacterium sp identified in Specimen

119

363

3.36

31.96

2.8

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

157

4.73

31.76

1.8

1.5

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

136

452

3.09

31.71

1.8

1.3

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

130

422

3.16

31.55

1.2

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

238

3.94

31.54

1.2

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

158

4.70

31.52

1.8

1.5

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

9.58

31.50

1.6

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

114

342

3.41

31.43

1.7

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

114

343

3.40

31.29

1.7

1.3

—

(3024471) HLA-A [Type]

6.34

31.22

1.0

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

524

3103

1.81

31.13

2.2

1.7

1.74

1.46

8.57

435

2741

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

8.75

31.03

5.1

3.8

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

114

345

3.38

31.01

1.7

1.3

—

(1175426) CD3 cells/100 lymphocytes in Blood

202

4.18

30.91

2.3

71.94

71.37

0.09

192

(3024932) HLA-DR beta [Type]

6.29

30.41

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

113

5.38

30.39

1.6

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

113

5.38

30.39

1.7

1.4

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

186

4.26

29.84

2.1

2.3

—

(3008037) Lactate [Moles/volume] in Venous blood

145

520

2.86

29.55

5.0

2.7

1.64

1.62

mmol/l

0.04

140

503

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

760

5059

1.64

29.31

4.9

3.3

303.12

608.82

ng/l

0.79

613

3884

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

167

653

2.63

28.82

4.0

3.4

1025.89

846.13

u/ml

0.09

157

600

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

201

4.05

28.57

1.7

1.2

—

(3048689) Calprotectin [Mass/mass] in Stool

543

3328

1.74

28.49

2.3

2.2

133.03

139.84

ug/g

0.22

422

2593

(3010375) cycloSPORINE [Mass/volume] in Blood

117

5.11

28.24

26.5

23.9

104.61

123.00

ug/l

1.02

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

6.44

26.88

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

329

1758

1.96

26.74

1.2

190.57

138.21

iu/ml

1.09

122

639

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

5.56

26.30

1.3

1.7

3.08

8.50

nmol/l

0.53

(3019977) pH of Arterial blood

113

5.02

26.29

2.6

7.42

0.15

(3022145) Colonoscopy Study observation

517

3196

1.72

26.15

1.4

1.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

192

840

2.36

26.08

1.9

1.5

0.38

10.78

iu/ml

0.72

170

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

127

454

2.86

26.05

2.2

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

127

454

2.86

26.05

2.2

1.5

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3045

27665

1.67

25.92

29.5

11.7

73.09

80.55

ml/min/173m2

44.57

2760

22746

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

396

2271

1.84

25.88

2.5

2.1

5.02

7.30

ug/l

3.04

331

1993

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

148

584

2.60

25.09

1.6

1.5

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3337

31213

2.01

24.79

37.3

14.6

97.53

76.19

umol/l

51.44

3337

31205

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

319

3.16

24.37

2.2

1.6

—

(21494814) CD8 cells/100 lymphocytes in Specimen

102

5.06

24.20

2.3

1.9

—

(3044889) 12 lead EKG panel

2355

20352

1.46

24.13

4.8

3.6

—

(3004451) EKG impression Narrative

5.11

24.00

1.5

1.3

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

247

3.46

23.95

2.4

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

247

3.46

23.95

2.4

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

247

3.46

23.95

2.4

1.6

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

5.79

23.66

1.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

184

3.86

23.53

2.2

2.4

524.48

656.59

e6/l

1.37

179

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

5.48

23.35

2.1

1.9

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

121

4.60

23.33

3.7

2.8

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

156

658

2.43

23.00

1.7

1.4

11.74

10.25

u/l

0.48

127

533

(3020191) Ethanol [Moles/volume] in Serum or Plasma

183

3.82

22.91

1.6

1.3

1.09

1.36

promille

0.64

143

(3038515) Glucose [Moles/volume] in Venous blood

127

487

2.67

22.82

5.5

2.8

7.24

7.41

mmol/l

0.30

122

475

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

292

3.17

22.58

2.2

1.7

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

411

2478

1.74

22.56

4.1

2.4

41.73

58.10

u/l

0.39

350

2122

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

7.95

22.14

6.1

5.9

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3326

31233

1.91

22.03

19.6

9.7

26.73

26.10

u/l

1.13

3263

29966

(3039000) Anion gap in Blood

135

544

2.54

21.95

9.5

6.9

11.70

11.05

mmol/l

1.14

125

479

(40761535) Cells panel - Urine sediment

406

2458

1.74

21.93

4.6

3.3

—

(3018572) Chloride [Moles/volume] in Blood

135

545

2.53

21.86

9.5

6.9

104.88

105.20

mmol/l

0.26

125

480

(3014148) Varicella zoster virus Ab [Titer] in Serum

284

3.15

21.64

1.2

1.1

—

(3003694) ABO and Rh group [Type] in Blood

1032

7777

1.46

21.53

1.5

1.4

—

(40761511) CBC panel - Blood by Automated count

3260

30464

1.78

21.40

30.5

11.9

—

(36660697) Celiac disease serology panel - Serum

362

2139

1.77

21.27

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

202

983

2.12

21.19

2.7

3.6

1079.56

1549.67

u/ml

0.15

178

825

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

161

716

2.31

21.08

1.6

1.3

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

387

2349

1.73

20.67

4.2

2.4

49.00

66.94

ml/min/173m2

15.46

209

901

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

147

3.99

20.54

2.7

3.0

39.35

41.43

0.36

(3024980) IgG subclass 4 [Mass/volume] in Serum

111

424

2.67

20.13

1.5

1.7

0.85

0.82

g/l

0.05

322

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

131

549

2.44

19.62

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

131

549

2.44

19.62

1.3

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

5.57

19.60

1.8

1.5

14.71

15.17

pmol/l

0.22

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2923

26729

1.51

19.51

7.8

5.2

40.37

39.22

mmol/mol

7.56

2698

24487

(21494434) Karyotype in Bone marrow

246

3.18

19.29

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

236

3.22

19.26

1.5

1.6

—

(3002385) Erythrocyte distribution width [Ratio]

2760

24976

1.46

19.21

36.4

14.9

15.44

15.20

0.56

2735

24471

(3011648) Oxygen content in Venous blood

169

3.65

19.07

3.1

3.8

10.12

11.46

1.48

169

(3016650) Hepatitis A virus Ab [Presence] in Serum

105

405

2.64

18.70

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

188

3.45

18.34

1.3

2.25

2.08

mmol/l

0.37

177

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

324

2.82

18.31

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

116

476

2.49

18.20

1.3

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

156

3.70

18.16

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

156

3.70

18.16

1.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

867

6495

1.44

18.13

4.6

3.6

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

172

836

2.11

18.11

1.9

1.7

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

161

763

2.16

18.09

1.9

1.6

331.11

300.58

mu/l

0.60

148

700

(3017732) Neutrophils [#/volume] in Blood

326

1956

1.73

18.08

3.0

2.8

5.15

4.68

e9/l

0.27

236

1584

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

133

583

2.33

18.03

1.2

1.4

3.87

3.70

mmol/l

0.85

123

548

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

135

602

2.29

17.60

3.3

2.1

254.85

100.54

ug/min

1.31

357

(3016750) Collection duration of Urine

146

3.74

17.51

3.3

2.0

498.23

490.54

min

0.21

103

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

137

3.84

17.50

2.9

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

137

3.84

17.50

2.9

1.8

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

155

734

2.16

17.46

2.6

210.77

187.02

2.33

145

697

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1997

17238

1.36

17.44

3.3

2.8

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

170

3.51

17.43

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

5.89

17.43

1.6

1.3

171.58

47.36

mu/l

0.87

(3004775) Volume in Urine collected for unspecified duration

200

3.29

17.34

3.0

2.1

704.50

643.71

0.55

127

(3036489) Thrombin time

189

968

2.01

17.28

2.3

2.1

21.50

21.36

0.17

171

838

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

42.19

17.27

6.0

1.2

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

221

3.16

17.25

1.8

1.5

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

181

3.41

17.23

2.3

2.6

510.19

502.05

e6/l

0.04

150

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

145

673

2.20

17.17

1.3

1.4

461.79

535.59

mg/l

1.64

136

634

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

119

510

2.38

17.00

1.7

1.6

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

7.19

16.94

1.6

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

367

2.63

16.90

1.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

670

4837

1.47

16.85

1.4

1.3

42.76

33.46

iu/ml

0.60

197

1521

(3015171) Extractable nuclear Ab [Units/volume] in Serum

202

1073

1.94

16.63

1.3

1.2

0.28

0.94

u/ml

1.31

(3026389) Candida sp identified in Specimen by Organism specific culture

371

2.60

16.54

1.9

1.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

115

493

2.38

16.43

3.2

2.0

1.05

0.78

nmol/l

2.48

413

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

266

2.86

15.73

1.3

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

324

2019

1.66

15.58

2.4

2.1

12.82

13.17

nmol/l

0.30

280

1823

(3034988) Calcium [Moles/volume] in Capillary blood

6.23

15.46

2.5

1.6

1.20

1.18

mmol/l

0.46

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

5.20

15.31

1.2

406.04

287.78

pmol/l

0.52

(3020911) Cortisol [Moles/time] in 24 hour Urine

5.04

15.24

1.5

1.2

86.09

182.57

nmol/24h

0.48

(4062490) Immunoglobulin typing, IgG

260

2.85

15.20

1.3

1.4

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

4.54

15.16

1.5

1.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

345

2200

1.63

15.14

3.5

2.7

241.32

183.27

ng/l

0.96

305

1997

(40768795) Lymph node Pathology biopsy report

289

2.74

15.09

1.5

1.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

632

4600

1.45

15.08

1.3

1.2

8.97

11.46

u/ml

0.54

229

1799

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

6.52

14.91

2.5

1.5

1.23

1.19

mmol/l

0.64

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

5.53

14.76

2.1

1.9

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

5.53

14.76

2.1

1.9

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

4.07

14.69

1.2

4.9

4341.47

66.28

mg/l

0.49

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

6.35

14.55

1.0

1.1

—

(3023419) Bacteria identified in Sputum by Culture

404

2.41

14.33

3.0

2.7

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

263

2.77

14.33

1.3

1.4

0.49

0.41

g/l

0.26

180

(3027135) IgG subclass 1 [Mass/volume] in Serum

263

2.77

14.33

1.3

1.4

7.07

6.65

g/l

0.31

181

(3028192) IgG subclass 2 [Mass/volume] in Serum

263

2.77

14.33

1.3

1.4

2.69

2.92

g/l

0.42

183

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

110

3.85

14.30

3.7

4.5

—

(40757494) Bilirubin.total [Moles/volume] in Blood

155

3.32

13.94

4.4

2.2

15.20

36.50

umol/l

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

4.14

13.92

2.2

2.9

177.92

146.04

umol/l

0.14

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

417

2.36

13.82

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

149

762

2.00

13.73

1.9

1.4

—

(3052851) Hemolysis interference index of Serum or Plasma

150

769

1.99

13.72

4.1

3.0

—

(3044290) Cell count panel - Cerebral spinal fluid

115

534

2.19

13.67

1.4

1.5

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

318

2.55

13.50

1.3

1.4

32.70

29.12

u/l

0.31

262

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

314

2.55

13.34

2.0

1.6

—

1286.67

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

116

3.65

13.28

3.1

1.9

—

(3002256) Pathology report gross observation

536

3867

1.45

13.27

1.3

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

122

587

2.12

13.26

1.4

1.5

18.43

18.65

e6/l

0.01

464

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

122

588

2.11

13.21

1.5

1.6

1204.01

1434.23

e6/l

0.09

101

488

(40765096) Chromosome analysis panel by Banding

3.87

13.05

1.2

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

5.93

13.05

1.5

1.4

—

(3014271) Vancomycin [Susceptibility]

113

3.66

13.01

3.8

2.7

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

5.03

12.88

1.2

1.3

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

5.35

12.76

1.4

2.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

115

3.59

12.68

3.2

1.9

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

115

3.59

12.68

3.2

1.9

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

4.01

12.62

1.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

116

3.56

12.53

2.7

2.1

—

(3049717) Cytology report of Urine Cyto stain

184

1044

1.80

12.37

2.2

2.6

—

(3003434) Protein [Mass/volume] in Pleural fluid

351

2.40

12.31

1.5

1.4

31.55

33.15

g/l

0.50

320

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

132

3.36

12.31

1.0

1.1

—

(3048879) Bone marrow aspiration report

4.10

12.29

1.6

1.8

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

123

3.44

12.19

1.3

1.8

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

441

2.23

12.18

1.2

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

144

3.22

12.03

1.1

1.4

5.14

5.97

u/l

0.69

125

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

139

3.27

12.03

1.0

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

130

667

1.98

11.91

4.9

4.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

177

2.97

11.82

1.3

1.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3018

28393

1.40

11.79

5.6

4.4

6.10

5.88

mmol/l

12.53

2746

25636

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

102

3.65

11.76

1.9

2.1

1389.60

2535.46

u/ml

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

22.95

11.56

1.2

1.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

4.19

11.52

1.1

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

180

2.92

11.48

1.3

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

180

2.92

11.48

1.3

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

340

2.35

11.30

1.4

1.3

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

336

2.35

11.14

2.1

1.6

69.33

58.51

1.65

211

(3033705) Calcium.ionized [Moles/volume] in Venous blood

282

2.48

11.05

3.9

2.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

130

685

1.93

11.05

2.7

2.2

1976.98

2881.82

u/l

0.21

280

(3027570) Oxalate [Moles/time] in 24 hour Urine

11.17

11.03

1.8

1.5

328.45

330.22

umol/24h

0.01

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

319

2.38

11.02

1.7

1.4

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

319

2.38

11.02

1.7

1.4

—

(3030313) Adrenal Ab [Titer] in Serum

13.91

10.95

1.3

1.0

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

128

3.23

10.80

1.7

1.4

1.38

1.11

nmol/l

0.82

102

(3036525) Urea [Moles/time] in 24 hour Urine

17.85

10.71

2.2

2.0

—

(3028433) Virus identified in Specimen by Culture

3.60

10.62

1.3

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

127

675

1.91

10.53

2.0

1.6

14485.55

11926.02

e6/l

0.30

488

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

3.57

10.46

1.1

1535.62

1491.79

miu/ml

0.08

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

+∞

10.42

6.4

0.0

39.60

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

148

3.00

10.25

1.1

0.94

1.09

u/l

1.88

(3023199) Leukocytes [#/volume] in Pleural fluid

313

2.33

10.10

1.5

1.4

1343.84

2251.77

e6/l

0.93

228

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

138

765

1.84

10.06

1.3

1.2

67.77

33.73

u/ml

—

(3009542) Hematocrit [Volume Fraction] of Blood

3377

32623

1.62

10.05

46.8

18.8

38.73

40.31

39.42

3190

30489

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

111

577

1.95

9.85

1.3

1.2

1.05

3.86

u/ml

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

3.91

9.84

1.4

1.3

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

3.99

9.76

1.9

1.5

3924.00

25894.80

e6/l

0.48

(3012441) Differential panel - Pleural fluid

263

2.42

9.69

1.6

1.5

—

(3007461) Platelets [#/volume] in Blood

3377

32652

1.60

9.65

46.6

18.7

250.76

249.84

e9/l

0.30

3332

31755

(3014765) Yersinia sp identified in Stool by Organism specific culture

140

790

1.80

9.65

1.4

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

117

3.18

9.58

2.4

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

8.37

9.54

4.1

1.8

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

149

2.91

9.53

1.1

8.73

15.67

nmol/l

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

139

786

1.80

9.52

1.4

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

140

794

1.79

9.49

1.4

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

166

2.79

9.48

1.6

—

(3010813) Leukocytes [#/volume] in Blood

3377

32666

1.59

9.46

46.6

18.7

7.05

6.65

e9/l

15.88

3325

31648

(3024731) MCV [Entitic volume]

3377

32666

1.59

9.46

46.3

18.7

91.91

91.09

17.92

3351

32127

(3035941) MCH [Entitic mass]

3377

32668

1.59

9.43

46.3

18.6

30.49

30.33

4.61

3351

32126

(3035947) Staphylolysin Ab [Units/volume] in Serum

103

3.32

9.43

1.1

—

3.50

iu/ml

—

(3005322) IgE [Units/volume] in Serum or Plasma

254

1685

1.55

9.40

1.3

267.91

219.84

u/ml

0.17

236

1552

(3026361) Erythrocytes [#/volume] in Blood

3377

32671

1.59

9.39

46.5

18.7

4.28

4.50

e12/l

83.49

3325

31671

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

4.51

9.29

4.4

2.3

—

(3000963) Hemoglobin [Mass/volume] in Blood

3377

32679

1.59

9.28

46.8

18.8

129.41

135.87

g/l

82.43

3351

32144

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

263

2.38

9.22

2.0

1.4

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

9.04

9.01

7.4

3.7

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

305

2.25

8.92

1.1

—

3.33

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

24.06

8.90

1.4

1.0

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

226

1479

1.56

8.90

3.2

3.5

58.78

69.17

u/ml

0.29

216

1428

(3019150) Specific gravity of Urine by Refractometry

753

6082

1.30

8.89

5.5

3.9

1.02

kg/l

1.50

120

839

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

108

579

1.89

8.79

1.3

1.2

—

6.29

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.79

8.77

1.3

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

4.25

8.65

1.3

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

141

2.86

8.63

13.6

12.0

0.72

0.63

mmol/l

2.21

129

(3017569) Oxygen content in Arterial blood

120

3.02

8.57

2.8

2.4

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

126

715

1.79

8.56

1.3

1.2

3.50

5.97

u/ml

0.84

129

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

125

708

1.79

8.55

1.3

1.2

3.15

2.88

u/ml

—

(3045424) Erythrocytes [Presence] in Urine

493

1.95

8.53

1.9

1.5

—

(3012989) Citrate [Moles/time] in 24 hour Urine

20.06

8.46

1.5

1.3

2.27

2.00

mmol/24h

—

(3016018) Differential panel - Cerebral spinal fluid

274

2.29

8.44

1.3

1.6

—

(3019832) Treponema pallidum Ab [Presence] in Serum

281

1951

1.48

8.39

1.8

1.6

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

125

714

1.78

8.32

1.1

4.27

6.60

u/ml

—

(3003327) Ova and parasites identified in Stool by Light microscopy

143

850

1.71

8.28

1.8

1.7

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

264

2.29

8.26

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

309

2.19

8.24

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

278

2.25

8.17

1.1

—

(3045788) Cell count panel - Pleural fluid

247

2.33

8.13

1.4

1.5

—

(40768806) Pleura Pathology biopsy report

279

2.24

8.10

1.5

—

(3021788) Differential panel - Synovial fluid

510

1.91

8.06

2.0

1.5

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

168

1055

1.62

7.90

1.6

1.4

26.17

29.98

iu/l

0.70

142

899

(3023487) Leukocytes [#/volume] in Peritoneal fluid

3.39

7.79

2.1

1.7

1084.75

688.67

e6/l

0.23

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

3.39

7.79

2.7

2.4

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

286

2.19

7.65

1.4

11270.46

66965.70

e6/l

1.32

165

(3052592) Norovirus Ag [Presence] in Stool

4.52

7.64

2.1

1.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

490

3807

1.33

7.56

12.2

6.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

220

1485

1.51

7.56

2.7

2.4

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

108

2.98

7.49

1.7

1.4

65.81

65.59

0.01

(3044941) Cell count panel - Synovial fluid

434

1.93

7.34

1.9

1.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

407

1.96

7.29

1.2

1.1

21.96

1369.78

iu/ml

0.54

(3008536) Aspergillus sp Ab [Presence] in Serum

3.83

7.24

2.5

1.6

—

(3032057) Clostridioides difficile [Presence] in Stool

4.06

7.07

1.4

1.9

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

206

2.35

7.04

1.2

1.1

39.36

36.41

mg/l

0.25

163

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

195

2.38

6.94

1.2

1.1

268.82

262.38

mg/l

0.09

166

(3026692) Albumin [Mass/volume] in Peritoneal fluid

3.70

6.90

1.6

1.2

11.83

14.16

g/l

0.46

(4146454) Self-monitoring of blood glucose

259

2.18

6.90

3.4

2.4

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

13.79

6.88

4.5

2.3

—

(3035880) pH of Pleural fluid

139

2.61

6.61

1.4

1.3

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

560

1.77

6.59

1.3

1.2

63.98

35.53

u/ml

—

(3000330) Specific gravity of Urine by Test strip

199

1355

1.50

6.59

4.9

3.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

254

1814

1.43

6.58

1.3

81.21

57.43

au/ml

—

116

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

274

1985

1.41

6.55

2.5

2.4

22.03

24.67

au/ml

—

143

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

117

2.75

6.53

1.3

1.2

—

(4200892) Spirometry reversibility

281

2051

1.40

6.44

1.4

—

(3029075) Extractable nuclear Ab panel - Serum

3.14

6.43

1.3

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

196

2.31

6.42

1.3

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

196

2.31

6.42

1.3

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

122

748

1.65

6.37

1.4

1.3

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

343

1.97

6.35

1.2

1.5

0.35

0.28

nmol/l

0.38

256

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

197

2.30

6.35

1.3

1.1

—

(3022621) pH of Urine by Test strip

254

1827

1.42

6.33

4.1

2.9

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

198

2.29

6.28

1.3

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

198

2.29

6.28

1.3

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

198

2.29

6.28

1.3

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

114

2.73

6.27

1.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

143

2.53

6.27

1.4

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

143

2.53

6.27

1.4

1.6

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

3.00

6.22

1.0

1.1

77.75

86.69

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

3.52

6.15

1.0

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

279

2.06

6.12

1.7

1.4

106583.59

65795.94

e6/l

0.23

197

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

4.12

6.08

1.1

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

4.12

6.08

1.9

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

189

2.29

6.03

1.2

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

114

701

1.65

5.91

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

8.02

5.83

1.1

1.0

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

472

3779

1.29

5.81

5.1

4.2

32.26

32.41

0.11

355

2517

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

268

2.03

5.62

4.5

4.0

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.89

5.61

1.0

1.1

85.25

86.47

—

(3006576) Bicarbonate [Moles/volume] in Blood

3.19

5.59

6.1

5.8

25.07

mmol/l

0.00

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

115

720

1.62

5.58

1.2

1.1

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

2.94

5.56

1.8

1.6

21.30

54.35

u/l

0.83

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2878

27542

1.23

5.55

4.7

3.7

1.43

1.26

mmol/l

26.01

2610

24939

(3039162) Centromere protein B Ab [Units/volume] in Serum

332

1.91

5.54

1.3

1.2

78.20

40.26

u/ml

—

(3006653) Thiamine [Moles/volume] in Blood

128

2.51

5.53

1.3

1.2

121.09

135.61

nmol/l

1.17

128

(3037692) Legionella sp identified in Specimen by Organism specific culture

105

2.68

5.49

1.4

1.2

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

3.10

5.33

1.9

1.3

15.69

31.88

1.75

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

5.02

5.24

2.0

1.5

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.84

5.24

3.5

2.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

5.93

5.21

1.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

283

1.96

5.20

2.1

1.5

20.36

30.68

1.80

173

(3027456) Digoxin [Moles/volume] in Serum or Plasma

524

1.70

5.20

3.5

3.1

0.83

0.81

nmol/l

0.14

401

(3044007) Cell count panel - Peritoneal fluid

3.14

5.18

1.9

1.5

—

(3043410) Blood group antigens tested for on Red Blood Cells

3.14

5.18

1.8

1.3

—

(3051651) Icteric interference index of Serum or Plasma

157

2.31

5.18

5.6

2.6

—

(3033799) Differential panel - Peritoneal fluid

3.01

5.09

2.0

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

13.36

5.08

1.3

1.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

175

2446

0.70

4.99

1.7

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

3.23

4.89

1.1

0.75

0.71

umol/24h

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

376

1.80

4.88

2.9

2.2

25.45

22.36

mg/l

0.16

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

155

2.27

4.88

1.8

1.6

—

(3006270) Folate [Moles/volume] in Blood

221

2.05

4.86

1.1

366.44

375.13

nmol/l

0.09

194

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

7.71

4.84

3.9

3.5

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

256

1.97

4.82

1.2

1.3

—

(4212803) Bone marrow aspirate examination

4.84

4.80

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

5.21

4.76

1.2

1.3

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

3.28

4.74

1.1

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

2.80

4.71

2.0

2.6

294.17

223.61

e6/l

0.24

(3045414) Leukocytes [Presence] in Urine

180

1291

1.42

4.63

2.1

1.7

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

14.02

4.57

5.1

5.2

461.71

380.60

umol/l

—

(3040893) Potassium [Moles/volume] in Capillary blood

14.02

4.57

3.0

1.6

4.47

4.30

mmol/l

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2962

28561

1.21

4.57

5.1

4.1

1.41

1.49

mmol/l

20.09

2716

26090

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

110

717

1.55

4.56

1.3

158.80

218.04

miu/ml

0.88

326

(3009466) Valproate [Moles/volume] in Serum or Plasma

348

1.80

4.54

6.0

5.1

350.75

359.51

umol/l

0.16

298

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

221

2.00

4.50

1.2

1.3

1.70

1.44

nmol/l

0.71

197

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

109

1632

0.66

4.50

1.5

1.4

—

(3000034) Microalbumin [Mass/volume] in Urine

228

1.99

4.49

4.0

2.7

229.20

15.39

mg/l

1.64

165

(40757373) Influenza virus identified in Isolate

3.16

4.48

1.4

1.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2981

28777

1.21

4.46

5.1

4.2

4.53

4.73

mmol/l

22.34

2747

26426

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

3.28

4.46

1.5

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

144

1002

1.46

4.38

1.6

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

3.21

4.33

1.1

1.0

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

399

1.72

4.30

1.2

3.11

3.62

u/ml

0.24

169

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

225

1.97

4.30

1.3

1.2

24.20

47.60

u/ml

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.79

4.28

1.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

11.69

4.27

1.1

1.0

—

mmol/l

—

(21494755) Public health laboratory ask at order entry panel

181

2447

0.73

4.26

1.2

1.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

853

7496

1.18

4.22

1.8

1.6

1.50

1.32

mmol/l

6.31

720

6198

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1059

9473

1.17

4.20

4.7

4.9

4.46

3.76

ug/l

0.36

931

8511

(3038071) Oxygen [Partial pressure] in Mixed venous blood

3.27

4.18

10.2

7.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

544

4595

1.22

4.15

1.6

1.5

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

174

2.08

4.11

1.5

1.4

17.44

12.84

u/l

1.33

167

(3034274) Bile acid [Moles/volume] in Serum --fasting

244

1.90

4.06

3.5

2.2

11.41

6.92

umol/l

0.36

174

(3034891) Synovial lining cells/100 cells in Synovial fluid

142

2.19

4.04

2.2

1.5

2.00

4.39

—

(3032773) Endomysium IgG Ab [Titer] in Serum

224

1.93

4.01

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

3.90

3.99

1.3

1.6

—

(3026480) Teichoate Ab [Titer] in Serum

5.57

3.97

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

2.43

3.96

2.5

2.0

44.28

52.82

umol/l

0.38

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.57

3.88

1.0

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

4.30

3.81

2.4

2.1

—

(40758292) HTLV I+II Ab panel - Serum

3.19

3.77

1.7

1.4

—

(3002619) Bacteria identified in Specimen by Culture

2.92

3.73

1.3

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

121

2.24

3.73

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

2.80

3.68

1.0

1.1

67.17

80.94

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

2.80

3.68

1.1

62.83

73.22

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

122

2.22

3.66

1.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3023

29344

1.19

3.61

5.5

4.6

2.63

2.81

mmol/l

22.37

2768

26766

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

163

2.03

3.59

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

4.01

3.59

2.4

2.1

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

4.01

3.59

1.3

1.4

75.00

70.87

0.18

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

2.95

3.57

10.3

7.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

213

1.89

3.53

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

187

1.93

3.43

1.7

1.6

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

146

2.06

3.41

1.8

1.7

1.76

3.69

u/field

0.69

(3004716) Salmonella sp identified in Stool by Organism specific culture

176

1328

1.34

3.41

1.4

1.3

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

570

1.52

3.40

2.2

1.8

203.17

210.55

pmol/l

0.22

544

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.39

3.39

1.0

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.76

3.38

1.1

1.2

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

140

2.08

3.37

1.1

1.5

6.05

8.12

ug/l

0.84

123

(3020123) Porphyrins [Interpretation] in Serum or Plasma

5.01

3.37

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

3.94

3.28

1.0

2.9

—

(40768443) Skin Pathology biopsy report

169

1276

1.34

3.27

1.3

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

3.34

3.22

1.1

1.2

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

5.01

3.05

1.5

1.6

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

119

2.11

3.04

1.1

1.0

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

106

2.18

3.02

1.3

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

225

1.79

3.02

1.7

2.1

2.78

1.83

u/field

0.66

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

5.84

3.02

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

270

1.71

3.01

4.8

2.5

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

189

1.86

3.01

1.7

1.4

82.54

79.31

umol/l

0.26

189

(3013139) Helicobacter pylori Ag [Presence] in Stool

242

1943

1.26

2.99

1.3

1.2

—

(3000492) Spirometry study

332

2761

1.22

2.98

1.5

1.4

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.75

2.98

1.4

1.5

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

120

2.09

2.98

1.0

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

10.01

2.98

1.0

1.8

—

(3019174) dRVVT (LA screen)

3.85

2.97

1.3

1.2

—

(3044009) aPTT.lupus sensitive (LA screen)

3.85

2.97

1.3

1.2

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

108

2.14

2.90

1.3

1.6

—

1635592.86

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

408

1.55

2.82

1.2

3.57

3.87

u/ml

0.06

143

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

3.24

2.72

1.0

—

(3014891) Appearance of Pleural fluid

3.24

2.72

1.0

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.24

2.72

1.1

1.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.43

2.70

1.3

—

(3035320) C reactive protein [Mass/volume] in Body fluid

182

1.82

2.69

3.5

2.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

4.22

2.67

1.0

1.5

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

3.15

2.64

11.8

9.9

0.22

0.40

umol/l

2.00

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.22

2.63

1.6

1.3

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

2.16

2.60

1.1

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.26

2.60

1.7

1.4

10.07

8.48

ug/l

0.83

(3013336) Amino acids [Identifier] in Serum or Plasma

7.15

2.55

11.0

2.7

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

7.15

2.55

1.0

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

2.86

2.54

1.2

0.91

3.14

mmol/l

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

363

1.55

2.53

1.1

1.60

2.65

u/ml

0.69

161

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.23

2.51

1.0

1.3

—

(3023410) Appearance of Cerebral spinal fluid

255

1.65

2.48

1.2

1.8

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.32

2.48

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

2.14

2.44

1.2

37.50

39.33

g/l

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

5.01

2.40

1.3

1.4

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

499

1.45

2.39

1.8

1.6

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

3.34

2.39

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

6.26

2.37

1.0

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

190

1.74

2.37

1.4

1.3

0.36

1.25

u/ml

0.98

108

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

402

1.50

2.36

1.2

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

4.12

2.36

1.0

1.5

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

169

1.78

2.32

1.2

1.1

1.07

1.04

ratio

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

112

1.97

2.30

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.46

2.27

1.6

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

178

1432

1.26

2.23

1.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.10

2.22

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.10

2.22

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

2.20

1.1

1.3

145.43

557.87

ug/l

—

(3024869) Neuronal Ab [Presence] in Serum

2.69

2.20

1.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

353

1.51

2.17

1.2

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.69

2.15

1.7

1.2

—

(3028707) Methadone [Presence] in Urine by Screen method

362

1.50

2.14

1.9

2.6

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

159

1.77

2.13

1.3

1.2

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

5.01

2.07

1.0

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

5.01

2.07

1.0

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

2.91

2.07

1.0

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.91

2.07

1.1

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.03

2.05

1.1

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

278

1.55

2.03

1.8

2.3

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.97

1.93

1.1

2.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.97

1.93

1.0

1.1

1.74

1.90

umol/24h

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

3.75

1.93

1.0

—

(3042517) Benzodiazepines panel - Urine

3.75

1.93

1.5

3.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.45

1.93

1.5

1.7

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.12

1.92

1.3

1.2

—

(3008898) HLA-B27 [Presence]

117

917

1.29

1.87

1.1

—

(3016879) Cocaine [Presence] in Urine

745

1.31

1.81

1.6

2.0

—

(3022689) Creatine [Moles/volume] in Urine

2.17

1.77

2.8

1.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

131

1.76

1.77

1.3

1.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

2.50

1.74

8.2

7.7

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.67

1.72

1.3

1.4

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

3.85

1.71

1.8

1.7

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.14

1.71

1.1

1.2

—

(3025577) Chromium [Mass/volume] in Blood

202

1.59

1.71

2.1

2.0

1.96

2.26

ug/l

0.38

168

(1001926) Buprenorphine [Presence] in Urine by Screen method

630

1.32

1.70

1.7

2.0

—

(3009871) Measles virus Ab [Titer] in Serum

1.91

1.69

1.8

1.7

—

(3028717) Thiamine [Mass/volume] in Blood

2.80

1.65

1.1

1.3

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

340

0.59

1.61

1.5

1.7

—

(3022475) Manganese [Moles/volume] in Blood

3.57

1.61

1.2

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.91

1.59

1.1

—

(3020491) Glucose [Moles/volume] in Blood

206

1.56

1.59

2.2

1.9

7.65

6.54

mmol/l

0.90

132

(3027008) Opiates [Presence] in Urine

103

814

1.27

1.58

1.6

1.9

—

(3000764) Benzodiazepines [Presence] in Urine

102

806

1.27

1.57

1.6

2.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.82

1.57

1.1

—

(40768793) Breast Pathology biopsy report

683

1.30

1.56

1.4

1.3

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

2.04

1.54

4.7

7.3

66.38

71.19

—

(3024263) Appearance of Synovial fluid

153

1.64

1.53

1.4

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

100

1.80

1.53

4.6

1.9

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

399

1.38

1.52

1.3

1.2

—

(3050794) Legionella sp Ab [Presence] in Serum

3.34

1.52

1.0

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

434

1.37

1.51

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

325

1.42

1.49

1.2

1.3

7.45

7.25

mmol/l

0.20

290

(3003338) MCHC [Mass/volume]

2387

24495

0.92

1.47

39.2

16.4

331.33

332.38

g/l

5.87

2374

24303

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.73

1.43

2.8

3.3

—

(3028300) Cannabinoids [Presence] in Urine

102

818

1.25

1.42

1.6

1.9

—

(3027944) Amphetamines [Presence] in Urine

100

801

1.26

1.41

1.6

1.9

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

397

1.37

1.40

1.1

—

(3000285) Sodium [Moles/volume] in Blood

2.25

1.40

1.2

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

372

1.38

1.39

1.0

1.1

122.27

114.62

0.75

334

(3013166) Neutrophils/100 leukocytes in Synovial fluid

104

1.73

1.36

1.4

1.3

61.39

55.57

0.28

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.87

1.34

1.8

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.10

1.30

1.4

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.10

1.30

1.4

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.10

1.30

1.4

1.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.40

1.24

1.0

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

350

0.65

1.22

1.4

—

(3011288) Drugs identified in Urine by Screen method

531

1.29

1.21

5.9

2.8

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

409

1.33

1.20

1.5

1.6

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.75

1.19

1.1

1.0

—

(3005033) Fetal Nuchal fold Thickness US

347

0.66

1.18

1.4

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

125

1.60

1.17

1.1

96.53

91.67

0.27

(3043238) Trisomy 21 risk [Likelihood] in Fetus

357

0.67

1.16

1.5

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.50

1.15

1.4

1.1

—

(1002224) Polysomnography panel

125

1057

1.19

1.10

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.19

1.08

1.3

1.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

121

0.50

1.05

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.77

1.00

1.3

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.77

1.00

1.3

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.77

1.00

1.3

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.77

1.00

1.3

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

132

1.52

0.97

1.0

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.22

0.93

1.0

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

126

1.51

0.91

1.9

2.1

244.83

101.66

ug/min

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.07

0.89

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

306

1.31

0.88

1.0

1.1

4.10

5.68

u/ml

0.20

125

(3051593) INR in Capillary blood by Coagulation assay

127

1.50

0.88

6.2

12.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

113

970

1.17

0.88

1.9

1.7

3.31

4.18

mg/l

0.52

689

(3020650) Glucose [Presence] in Urine

1.61

0.87

1.2

1.6

—

(3032868) Hemoglobin electrophoresis panel in Blood

2.00

0.87

1.5

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

784

0.83

0.80

1.3

1.5

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.52

0.78

1.4

1.5

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

157

1.40

0.76

1.1

1.5

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

226

1.33

0.76

1.6

1.4

2.52

4.23

ug/l

0.63

193

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.57

0.74

1.6

1.8

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.00

0.72

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.80

0.72

1.0

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

335

1.26

0.71

1.1

1.42

3.20

u/ml

1.62

158

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.58

0.71

1.0

1.1

—

(3001729) Color of Synovial fluid

1.92

0.70

1.4

1.7

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.92

0.70

3.0

2.1

0.20

0.73

u/field

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.71

0.70

1.6

1.5

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.85

0.68

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.60

0.68

1.4

1.2

—

(3006462) Nitrate [Presence] in Urine

146

1.37

0.63

4.9

3.5

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

561

1.18

0.63

5.3

3.3

28.57

27.72

mg/l

0.06

335

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

113

1272

0.88

0.62

1.8

1.9

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

280

0.75

0.62

1.1

1.5

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

1.52

0.62

2.7

34.80

29.00

umol/l

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

102

0.59

0.62

2.2

2.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.67

0.61

1.0

1.1

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.1

—

0.60

—

(3039443) Prostate specific Ag panel - Serum or Plasma

597

0.84

0.60

1.3

1.6

—

(3036180) Methadone [Presence] in Urine

1.45

0.59

1.5

1.8

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

0.58

0.0

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

125

0.64

0.54

1.3

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.50

0.54

1.0

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

426

0.82

0.53

1.3

1.4

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

187

1.29

0.52

2.0

1.5

0.94

0.95

g/l

0.06

187

(4034850) Laboratory test

106

950

1.12

0.52

14.4

8.9

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

425

0.82

0.52

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

424

0.82

0.51

1.3

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

423

0.83

0.50

1.3

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

466

0.84

0.50

1.4

1.5

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1014

0.89

0.47

1.8

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

375

0.83

0.46

1.3

1.6

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

147

1.29

0.45

1.2

1.3

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

219

0.78

0.43

1.4

1.5

223.99

218.03

pmol/l

0.03

219

(4281824) Cell count and differential, peritoneal fluid

294

1.19

0.42

1.2

1.1

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

1.56

0.42

1.0

1.7

10.78

4.20

nmol/l

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

231

2173

1.07

0.42

2.1

1.9

—

(3003577) Lead [Moles/volume] in Blood

0.00

0.41

0.0

1.4

—

0.14

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.43

0.39

1.0

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

270

1.19

0.38

1.3

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

280

0.82

0.38

1.3

1.5

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

228

2410

0.94

0.37

1.3

1.4

—

(3025130) Human papilloma virus identified in Specimen

332

0.84

0.36

1.3

1.7

—

(3015183) Erythrocyte sedimentation rate

135

0.74

0.36

1.1

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

858

0.91

0.35

1.3

1.5

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.40

0.35

3.8

2.2

12.68

17.83

umol/l

—

(3014051) Protein [Presence] in Urine by Test strip

742

1.09

0.31

3.2

2.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

254

2428

1.05

0.30

2.3

2.0

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

183

0.82

0.27

1.1

1.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

177

1.19

0.27

1.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

0.68

0.26

3.4

1.6

2.14

1.92

ug/l

—

(3002523) Influenza virus A Ag [Presence] in Specimen

425

0.89

0.25

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

492

1.10

0.25

1.1

0.42

1.92

u/ml

4.06

270

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

124

1.21

0.24

1.1

9.80

6.75

u/ml

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.25

0.22

1.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.19

0.21

2.4

3.3

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.19

0.21

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.1

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

12.6

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

402

1.10

0.20

1.0

1.1

3.33

1.79

u/ml

0.47

213

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.20

0.0

1.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

278

1.12

0.20

1.0

1.1

0.03

0.33

u/ml

1.94

(3003740) Influenza virus B Ag [Presence] in Specimen

427

0.91

0.19

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

907

0.95

0.17

1.5

1.4

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

417

1.08

0.16

1.1

0.66

1.35

u/ml

0.62

199

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

770

7598

1.02

0.15

4.1

4.2

22.21

21.64

0.42

381

3812

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

0.80

0.14

2.6

3.7

7.41

7.66

mg/l

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

208

1.11

0.14

1.0

905.80

732.71

ng/l

0.75

133

(3014599) Egg white IgE Ab [Units/volume] in Serum

149

0.87

0.13

1.0

1.1

0.42

1.35

u/ml

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

132

1.14

0.13

1.0

1.1

0.16

5.19

u/ml

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

158

0.89

0.12

1.1

1.3

1.64

1.57

g/l

0.39

158

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

886

1.04

0.11

2.0

1.7

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

211

1.09

0.11

1.0

28.23

48.43

ng/l

3.00

138

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

303

2976

1.02

0.11

1.5

1.6

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

558

5514

1.01

0.10

3.0

0.90

0.75

ug/l

1.06

388

3693

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

421

4269

0.98

0.10

1.4

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

1.11

0.09

1.0

1.1

102.06

74.40

ug/l

—

(3051101) Glucose [Moles/volume] in Cord blood

1.04

0.09

3.2

6.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

130

1331

0.98

0.08

1.8

1.7

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

430

1.05

0.08

1.1

2.66

4.36

u/ml

0.65

233

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.09

0.08

1.1

1.0

—

(1761868) Lipid panel - Serum or Plasma

996

10013

0.99

0.06

3.3

2.7

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

209

1.05

0.04

1.0

318.14

344.95

ng/l

0.11

138

(4094501) Cardiovascular stress test using bicycle ergometer

765

1.02

0.04

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

151

1.06

0.03

1.1

0.35

1.40

u/ml

—

(1617658) Protocol used for examination of sentinel lymph nodes

252

1.03

0.02

1.0

1.1

—

(3034426) Prothrombin time (PT)

1.08

0.02

1.1

1.2

—

(40768800) Prostate Pathology biopsy report

602

1.01

0.01

1.3

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

125

0.96

0.00

1.4

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

185

1.03

0.00

1.1

—

(44813793) Dust mix specific IgE antibody measurement

185

1.03

0.00

1.1

1.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

506

1.01

0.00

1.3

1.4

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

1138.33

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

1.14

—

(3035933) Granulocytes/100 leukocytes in Blood

0.95

-0.00

1.8

1.4

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

-0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.6

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3022670) pH of Venous cord blood

0.00

-0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

2.38

—

(3007463) Buprenorphine [Presence] in Urine

0.00

-0.00

0.0

5.4

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.3

—

Mortality – FinRegistry

↥

Association

Association between endpoint E4_MINERAL_MET and mortality.

Females

Parameter	HR [95% CI]	p-value
E4_MINERAL_MET	2.617 [2.34, 2.93]	< 0.001
Birth year	0.996 [0.99, 1.0]	0.322

During the follow-up period (1.1.1998 — 31.12.2019), 3027 out of 8828 females with E4_MINERAL_MET died.

Males

Parameter	HR [95% CI]	p-value
E4_MINERAL_MET	3.794 [3.25, 4.43]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.009

During the follow-up period (1.1.1998 — 31.12.2019), 2295 out of 5987 males with E4_MINERAL_MET died.

Mortality risk

Mortality risk for people of age

years, who have E4_MINERAL_MET.

N-year risk	Females	Males
1	0.258%	0.65%
5	1.569%	4.37%
10	4.004%	10.145%
15	7.557%	18.812%
20	12.678%	31.367%

Relationships between endpoints

↥

Index endpoint: E4_MINERAL_MET – Disorders of mineral metabolism

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Disorders of mineral metabolism

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints